Journal Article
. 2013 Aug;24(9).
doi: 10.1093/annonc/mdt303.

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

A Goldhirsch 1 E P Winer  A S Coates  R D Gelber  M Piccart-Gebhart  B Thürlimann  H-J Senn  Panel members  
Affiliations
  • PMID: 23917950
  •     108 References
  •     904 citations

Abstract

The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer, supporting less extensive surgery to the axilla and shorter durations of radiation therapy. It refined its earlier approach to the classification and management of luminal disease in the absence of amplification or overexpression of the Human Epidermal growth factor Receptor 2 (HER2) oncogene, while retaining essentially unchanged recommendations for the systemic adjuvant therapy of HER2-positive and 'triple-negative' disease. The Panel again accepted that conventional clinico-pathological factors provided a surrogate subtype classification, while noting that in those areas of the world where multi-gene molecular assays are readily available many clinicians prefer to base chemotherapy decisions for patients with luminal disease on these genomic results rather than the surrogate subtype definitions. Several multi-gene molecular assays were recognized as providing accurate and reproducible prognostic information, and in some cases prediction of response to chemotherapy. Cost and availability preclude their application in many environments at the present time. Broad treatment recommendations are presented. Such recommendations do not imply that each Panel member agrees: indeed, among more than 100 questions, only one (trastuzumab duration) commanded 100% agreement. The various recommendations in fact carried differing degrees of support, as reflected in the nuanced wording of the text below and in the votes recorded in supplementary Appendix S1, available at Annals of Oncology online. Detailed decisions on treatment will as always involve clinical consideration of disease extent, host factors, patient preferences and social and economic constraints.

Keywords: St Gallen Consensus; early breast cancer; radiation therapy; subtypes; surgery; systemic adjuvant therapies.

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.
R Coleman, R de Boer, +13 authors, N Bundred.
Ann Oncol, 2012 Oct 11; 24(2). PMID: 23047045
Highly Cited.
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).
Benjamin D Smith, Douglas W Arthur, +11 authors, Jay R Harris.
Int J Radiat Oncol Biol Phys, 2009 Jun 24; 74(4). PMID: 19545784
Highly Cited.
Hypofractionation in the era of modulated radiotherapy (RT).
Kent W Mouw, Jay R Harris.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074773
Review.
Close/positive margins after breast-conserving therapy: additional resection or no resection?
William C Wood.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074771
Review.
Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer.
Peter S Hall, Christopher McCabe, Robert C Stein, David Cameron.
J Natl Cancer Inst, 2011 Dec 06; 104(1). PMID: 22138097
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Xavier Pivot, Gilles Romieu, +18 authors, PHARE trial investigators.
Lancet Oncol, 2013 Jun 15; 14(8). PMID: 23764181
Highly Cited.
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Felix Sedlmayer, Franz Zehentmayr, Gerd Fastner.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074775
Review.
Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?
Gunter von Minckwitz, Caterina Fontanella.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074777
Review.
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
José Baselga, Mario Campone, +18 authors, Gabriel N Hortobagyi.
N Engl J Med, 2011 Dec 14; 366(6). PMID: 22149876    Free PMC article.
Highly Cited.
A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.
J A Davidson, I Cromwell, +15 authors, S K Chia.
Eur J Cancer, 2013 Apr 25; 49(11). PMID: 23611660
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat, Maggie Chon U Cheang, +8 authors, Charles M Perou.
J Clin Oncol, 2012 Dec 13; 31(2). PMID: 23233704    Free PMC article.
Highly Cited.
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs.
Thordur Oskarsson, Swarnali Acharyya, +7 authors, Joan Massagué.
Nat Med, 2011 Jun 28; 17(7). PMID: 21706029    Free PMC article.
Highly Cited.
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
Robert S Kerbel, Eric Guerin, +4 authors, Shan Man.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074794
Review.
Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
Elizabeth J Folkerd, J Michael Dixon, +2 authors, Mitch Dowsett.
J Clin Oncol, 2012 Jul 18; 30(24). PMID: 22802308
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
Eitan Amir, Bostjan Seruga, +2 authors, Alberto Ocaña.
J Natl Cancer Inst, 2011 Jul 12; 103(17). PMID: 21743022
Highly Cited. Systematic Review.
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
Michael J Hassett, Samuel M Silver, +12 authors, Jane C Weeks.
J Clin Oncol, 2012 May 16; 30(18). PMID: 22585699    Free PMC article.
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, K Pritchard.
Lancet, 2011 Dec 14; 379(9814). PMID: 22152853    Free PMC article.
Highly Cited.
Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.
Ivana Sestak, Wolfgang Distler, +3 authors, Jack Cuzick.
J Clin Oncol, 2010 Jun 16; 28(21). PMID: 20547990
Breast-cancer adjuvant therapy with zoledronic acid.
Robert E Coleman, Helen Marshall, +17 authors, AZURE Investigators.
N Engl J Med, 2011 Oct 15; 365(15). PMID: 21995387
Highly Cited.
Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.
John Hornberger, Leon E Cosler, Gary H Lyman.
Am J Manag Care, 2005 May 19; 11(5). PMID: 15898220
Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer.
Daphne T Tsoi, Miho Inoue, +2 authors, Kathleen I Pritchard.
Oncologist, 2010 Apr 28; 15(5). PMID: 20421264    Free PMC article.
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Elisabeth Luporsi, Fabrice André, +22 authors, Jean-Pierre Bellocq.
Breast Cancer Res Treat, 2011 Nov 04; 132(3). PMID: 22048814    Free PMC article.
Highly Cited. Review.
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer.
Burton F Vanderlaan, Michael S Broder, +2 authors, Tanya G K Bentley.
Am J Manag Care, 2011 Aug 09; 17(7). PMID: 21819166
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
Marieke E Straver, Annuska M Glas, +7 authors, Sjoerd Rodenhuis.
Breast Cancer Res Treat, 2009 Feb 14; 119(3). PMID: 19214742
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
Viviana Galimberti, Edoardo Botteri, +12 authors, Umberto Veronesi.
Breast Cancer Res Treat, 2011 Apr 07; 131(3). PMID: 21468637
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Michael Gnant, Brigitte Mlineritsch, +18 authors, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
Lancet Oncol, 2011 Jun 07; 12(7). PMID: 21641868
Highly Cited.
Locoregional recurrence risk after lipofilling in breast cancer patients.
J Y Petit, E Botteri, +11 authors, N Rotmensz.
Ann Oncol, 2011 May 26; 23(3). PMID: 21610155
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer.
Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric.
BMC Cancer, 2012 Oct 04; 12. PMID: 23031196    Free PMC article.
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, +17 authors, Philip S Bernard.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204204    Free PMC article.
Highly Cited.
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, +25 authors, International Breast Cancer Study Group Trial 23-01 investigators.
Lancet Oncol, 2013 Mar 16; 14(4). PMID: 23491275    Free PMC article.
Highly Cited.
Extended adjuvant chemotherapy in endocrine non-responsive disease.
Marco Colleoni, Elisabetta Munzone.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074780
Review.
Association between breast cancer subtypes and response to neoadjuvant anastrozole.
Anita K Dunbier, Helen Anderson, +5 authors, Mitch Dowsett.
Steroids, 2011 Mar 31; 76(8). PMID: 21447351
Targeting adjuvant chemotherapy: a good idea that needs to be proven!
Daniel F Hayes.
J Clin Oncol, 2012 Feb 23; 30(12). PMID: 22355050
Review.
Whole-genome analysis informs breast cancer response to aromatase inhibition.
Matthew J Ellis, Li Ding, +56 authors, Elaine R Mardis.
Nature, 2012 Jun 23; 486(7403). PMID: 22722193    Free PMC article.
Highly Cited.
From genome to bedside: are we lost in translation?
Daniel F Hayes.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074786
Review.
Nutrition and physical activity influence on breast cancer incidence and outcome.
Rowan T Chlebowski.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074789
Review.
Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Christina A Clarke, Theresa H M Keegan, +4 authors, James V Lacey.
J Natl Cancer Inst, 2012 Jul 10; 104(14). PMID: 22773826    Free PMC article.
Highly Cited.
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
E de Azambuja, F Cardoso, +7 authors, M Paesmans.
Br J Cancer, 2007 Apr 25; 96(10). PMID: 17453008    Free PMC article.
Highly Cited.
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Hervé Bonnefoi, Martine Piccart, +19 authors, EORTC 10994/BIG 1-00 Study Investigators.
Lancet Oncol, 2011 May 17; 12(6). PMID: 21570352    Free PMC article.
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).
Csaba Polgár, Erik Van Limbergen, +12 authors, GEC-ESTRO breast cancer working group.
Radiother Oncol, 2010 Feb 26; 94(3). PMID: 20181402
Highly Cited.
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, +12 authors, SOFT/TEXT/PERCHE Steering Committee and the International Breast Cancer Study Group.
Ann Oncol, 2008 Mar 08; 19(7). PMID: 18325918
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.
Marianne Ewertz, Kathryn P Gray, +14 authors, Henning T Mouridsen.
J Clin Oncol, 2012 Oct 10; 30(32). PMID: 23045588    Free PMC article.
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.
Maggie C U Cheang, K David Voduc, +15 authors, Torsten O Nielsen.
Clin Cancer Res, 2012 Feb 22; 18(8). PMID: 22351696    Free PMC article.
Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan.
Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi.
Breast Cancer Res Treat, 2012 Feb 09; 133(2). PMID: 22315134
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Pratyaksha Wirapati, Christos Sotiriou, +10 authors, Mauro Delorenzi.
Breast Cancer Res, 2008 Jul 30; 10(4). PMID: 18662380    Free PMC article.
Highly Cited.
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer.
Ana P Kiess, Heather L McArthur, +5 authors, Beryl McCormick.
Cancer, 2011 Sep 03; 118(8). PMID: 21887681
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition.
Yasir H Ibrahim, Celina García-García, +18 authors, José Baselga.
Cancer Discov, 2012 Aug 24; 2(11). PMID: 22915752    Free PMC article.
Highly Cited.
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, +19 authors, International Ki-67 in Breast Cancer Working Group.
J Natl Cancer Inst, 2011 Oct 01; 103(22). PMID: 21960707    Free PMC article.
Highly Cited.
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
A Goldhirsch, W C Wood, +4 authors, Panel members.
Ann Oncol, 2011 Jun 29; 22(8). PMID: 21709140    Free PMC article.
Highly Cited.
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Torsten O Nielsen, Joel S Parker, +12 authors, Matthew J Ellis.
Clin Cancer Res, 2010 Sep 15; 16(21). PMID: 20837693    Free PMC article.
Highly Cited.
Estrogen receptor prevents p53-dependent apoptosis in breast cancer.
Shannon T Bailey, Hyunjin Shin, +2 authors, Myles Brown.
Proc Natl Acad Sci U S A, 2012 Oct 19; 109(44). PMID: 23077249    Free PMC article.
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
P E Goss, J N Ingle, +11 authors, D Tu.
Ann Oncol, 2012 Oct 03; 24(2). PMID: 23028039    Free PMC article.
The continued evidence from overviews: what is the clinical utility?
Natalie Turner, Laura Biganzoli, +6 authors, Angelo Di Leo.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074798
Review.
Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
Aron Goldhirsch.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074788
Review.
TP53 status and response to treatment in breast cancers.
Mariana Varna, Guilhem Bousquet, +2 authors, Anne Janin.
J Biomed Biotechnol, 2011 Jul 16; 2011. PMID: 21760703    Free PMC article.
Review.
Is adjuvant chemotherapy useful for women with luminal a breast cancer?
Alan S Coates, Marco Colleoni, Aron Goldhirsch.
J Clin Oncol, 2012 Feb 23; 30(12). PMID: 22355052
Review.
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, +7 authors, Monica Morrow.
JAMA, 2011 Feb 10; 305(6). PMID: 21304082    Free PMC article.
Highly Cited.
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
Giuseppe Viale, Meredith M Regan, +16 authors, International Breast Cancer Study Group.
J Natl Cancer Inst, 2008 Jan 31; 100(3). PMID: 18230798
Long-term results of hypofractionated radiation therapy for breast cancer.
Timothy J Whelan, Jean-Philippe Pignol, +12 authors, Carolyn Freeman.
N Engl J Med, 2010 Feb 12; 362(6). PMID: 20147717
Highly Cited.
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
Saroj Niraula, Alberto Ocana, Marguerite Ennis, Pamela J Goodwin.
Breast Cancer Res Treat, 2012 May 09; 134(2). PMID: 22562122
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.
Ashish Juvekar, Laura N Burga, +14 authors, Gerburg M Wulf.
Cancer Discov, 2012 Aug 24; 2(11). PMID: 22915751    Free PMC article.
Highly Cited.
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
Luca Gianni, Milvia Zambetti, +14 authors, Steven Shak.
J Clin Oncol, 2005 Sep 08; 23(29). PMID: 16145055
Highly Cited.
Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND).
Oreste Gentilini, Umberto Veronesi.
Breast, 2012 Jul 28; 21(5). PMID: 22835916
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.
James G Jackson, Vinod Pant, +9 authors, Guillermina Lozano.
Cancer Cell, 2012 Jun 16; 21(6). PMID: 22698404    Free PMC article.
Highly Cited.
Characterization and clinical impact of residual disease after neoadjuvant chemotherapy.
Giuseppe Viale.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074800
Review.
Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
J U Blohmer, M Rezai, +6 authors, W Eiermann.
J Med Econ, 2012 Sep 13; 16(1). PMID: 22966753
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial.
Aron Goldhirsch, Richard D Gelber, +23 authors, Herceptin Adjuvant (HERA) Trial Study Team.
Lancet, 2013 Jul 23; 382(9897). PMID: 23871490
Highly Cited.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
P Dubsky, M Filipits, +17 authors, Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Ann Oncol, 2012 Oct 05; 24(3). PMID: 23035151    Free PMC article.
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, +136 authors, Consortium of Investigators of Modifiers of BRCA1/2.
Cancer Epidemiol Biomarkers Prev, 2011 Dec 07; 21(1). PMID: 22144499    Free PMC article.
Highly Cited.
Follow-up tests to detect recurrent disease: patient's reassurance or medical need?
Ian E Smith, Gaia Schiavon.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074779
Review.
Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study.
G Buckland, N Travier, +47 authors, E Riboli.
Int J Cancer, 2012 Nov 28; 132(12). PMID: 23180513
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
Georg Pfeiler, Robert Königsberg, +13 authors, Michael Gnant.
J Clin Oncol, 2011 May 11; 29(19). PMID: 21555684
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
M Railo, J Lundin, +3 authors, S Nordling.
Acta Oncol, 1997 Jan 01; 36(4). PMID: 9247096
Adjuvant chemotherapy in older women with early-stage breast cancer.
Hyman B Muss, Donald A Berry, +23 authors, CALGB Investigators.
N Engl J Med, 2009 May 15; 360(20). PMID: 19439741    Free PMC article.
Highly Cited.
Personalizing extent of breast cancer surgery according to molecular subtypes.
Monica Morrow.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074769
Review.
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.
W Eiermann, M Rezai, +13 authors, J Blohmer.
Ann Oncol, 2012 Nov 09; 24(3). PMID: 23136233    Free PMC article.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, +36 authors, Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.
Lancet, 2012 Dec 12; 381(9869). PMID: 23219286    Free PMC article.
Highly Cited.
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
Helen Trihia, Susan Murray, +8 authors, International Breast Cancer Study Group.
Cancer, 2003 Feb 25; 97(5). PMID: 12599241
Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancer.
Maysa Abu-Khalf, Lajos Pusztai.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074799
Review.
Adipose tissue cells, lipotransfer and cancer: a challenge for scientists, oncologists and surgeons.
Francesco Bertolini, Visnu Lohsiriwat, Jean-Yves Petit, Mikhail G Kolonin.
Biochim Biophys Acta, 2012 May 02; 1826(1). PMID: 22546620
Review.
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
A A Sahin, J Ro, +7 authors, A G Ayala.
Cancer, 1991 Aug 01; 68(3). PMID: 1648433
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.
C A Drukker, J M Bueno-de-Mesquita, +10 authors, S C Linn.
Int J Cancer, 2013 Feb 02; 133(4). PMID: 23371464    Free PMC article.
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, +14 authors, Sibylle Loibl.
J Clin Oncol, 2012 Apr 18; 30(15). PMID: 22508812
Highly Cited.
Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network.
Nature, 2012 Sep 25; 490(7418). PMID: 23000897    Free PMC article.
Highly Cited.
MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
R L Jansen, P S Hupperets, +4 authors, H F Hillen.
Br J Cancer, 1998 Aug 26; 78(4). PMID: 9716027    Free PMC article.
Obesity and hormone therapy in breast cancer: an unfinished puzzle.
Pamela J Goodwin, Kathleen I Pritchard.
J Clin Oncol, 2010 Jun 16; 28(21). PMID: 20548001
Patients with triple negative breast cancer: is there an optimal adjuvant treatment?
Harold J Burstein.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074776
Review.
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
Carsten Denkert, Sibylle Loibl, +14 authors, Gunter von Minckwitz.
J Clin Oncol, 2009 Nov 18; 28(1). PMID: 19917869
Highly Cited.
Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.
Shelby D Reed, Michaela A Dinan, Kevin A Schulman, Gary H Lyman.
Genet Med, 2012 Sep 15; 15(3). PMID: 22975761    Free PMC article.
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, +10 authors, Torsten O Nielsen.
J Natl Cancer Inst, 2009 May 14; 101(10). PMID: 19436038    Free PMC article.
Highly Cited.
Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies.
Ana Catarina Pinto, Felipe Ades, Evandro de Azambuja, Martine Piccart-Gebhart.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074778
Review.
Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
Mitch Dowsett, Ian E Smith, +8 authors, IMPACT Trialists Group.
J Natl Cancer Inst, 2007 Jan 18; 99(2). PMID: 17228000
Highly Cited.
The genomic landscape of breast cancer as a therapeutic roadmap.
Matthew J Ellis, Charles M Perou.
Cancer Discov, 2013 Jan 16; 3(1). PMID: 23319768    Free PMC article.
Highly Cited.
Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
Rachel C Jankowitz, Kandace P McGuire, Nancy E Davidson.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074781
Review.
Adipose tissue and breast cancer progression: a link between metabolism and cancer.
Francesco Bertolini.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074792
Review.
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
Sherene Loi, Nicolas Sirtaine, +13 authors, Christos Sotiriou.
J Clin Oncol, 2013 Jan 24; 31(7). PMID: 23341518
Highly Cited.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
Paul E Goss, James N Ingle, +15 authors, Joseph L Pater.
N Engl J Med, 2003 Oct 11; 349(19). PMID: 14551341
Highly Cited.
Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial.
Gabriele Martelli, Patrizia Boracchi, +4 authors, Roberto Agresti.
Ann Surg, 2012 Nov 17; 256(6). PMID: 23154393
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.
A Prat, J S Parker, +9 authors, C M Perou.
Ann Oncol, 2012 Apr 26; 23(11). PMID: 22532584    Free PMC article.
Partial breast irradiation: targeting volume or breast molecular subtypes?
Roberto Orecchia, Maria Cristina Leonardi.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074774
Review.
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Giuseppe Viale, Anita Giobbie-Hurder, +18 authors, Breast International Group Trial 1-98.
J Clin Oncol, 2008 Nov 05; 26(34). PMID: 18981464    Free PMC article.
Highly Cited.
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.
Nathan W D Lamond, Chris Skedgel, +2 authors, Tallal Younis.
Breast Cancer Res Treat, 2012 Mar 01; 133(3). PMID: 22361999
Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization.
Shmuel H Klang, Ariel Hammerman, +3 authors, John Hornberger.
Value Health, 2010 Apr 24; 13(4). PMID: 20412544
Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.
Attiqa N Mirza, Nadeem Q Mirza, Georges Vlastos, S Eva Singletary.
Ann Surg, 2001 Dec 26; 235(1). PMID: 11753038    Free PMC article.
Review.
Sex hormones and breast cancer risk and prognosis.
Elizabeth Folkerd, Mitch Dowsett.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074790
Review.
Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitors.
James N Ingle.
Breast, 2013 Oct 01; 22 Suppl 2. PMID: 24074784
Review.
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.
Wenjing Zhou, Karin Jirström, +6 authors, Fredrik Wärnberg.
BMC Cancer, 2013 Nov 01; 13. PMID: 24171825    Free PMC article.
Collective invasion in breast cancer requires a conserved basal epithelial program.
Kevin J Cheung, Edward Gabrielson, Zena Werb, Andrew J Ewald.
Cell, 2013 Dec 18; 155(7). PMID: 24332913    Free PMC article.
Highly Cited.
For or against adjuvant trastuzumab for pT1a-bN0M0 breast cancer patients with HER2-positive tumors: a meta-analysis of published literatures.
Qiong Zhou, Wenjin Yin, Yueyao Du, Jinsong Lu.
PLoS One, 2014 Jan 07; 9(1). PMID: 24392090    Free PMC article.
[Determination of proliferation in breast cancer by immunohistochemical detection of Ki-67].
M Christgen, W Winkens, H H Kreipe.
Pathologe, 2014 Jan 15; 35(1). PMID: 24414612
Reply to: prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer.
A Goldhirsch, A S Coates.
Ann Oncol, 2014 Jan 25; 25(3). PMID: 24458471    Free PMC article.
Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China.
Jing Li, Yuan Huang, +14 authors, Jia-Yuan Li.
PLoS One, 2014 Feb 04; 9(1). PMID: 24489874    Free PMC article.
Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer--a problem still to be solved.
M Schmidt, M Untch.
Ann Oncol, 2014 Feb 07; 25(3). PMID: 24500980    Free PMC article.
Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
Ahmet Dirican, Betul Bolat Kucukzeybek, +13 authors, Mustafa Oktay Tarhan.
Int J Clin Oncol, 2014 Feb 18; 20(1). PMID: 24532163
Genomic profiling in luminal breast cancer.
Oleg Gluz, Daniel Hofmann, +3 authors, Nadia Harbeck.
Breast Care (Basel), 2014 Feb 20; 8(6). PMID: 24550749    Free PMC article.
Review.
Radiation oncologists' view on the zurich consensus.
Rainer Souchon, Marie-Luise Sautter-Bihl, +4 authors, Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).
Breast Care (Basel), 2014 Feb 20; 8(6). PMID: 24550754    Free PMC article.
Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor.
Ulrik Narbe, Pär-Ola Bendahl, +3 authors, Mårten Fernö.
Springerplus, 2014 Feb 26; 3. PMID: 24567879    Free PMC article.
Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.
Mustafa Al-Mubarak, Ariadna Tibau, +4 authors, Eitan Amir.
PLoS One, 2014 Mar 04; 9(2). PMID: 24586311    Free PMC article.
Systematic Review.
Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
Chuang Chen, Jing-Ping Yuan, +6 authors, Yan Li.
Int J Nanomedicine, 2014 Mar 05; 9. PMID: 24591826    Free PMC article.
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
EBCTCG (Early Breast Cancer Trialists' Collaborative Group), P McGale, +11 authors, S Darby.
Lancet, 2014 Mar 25; 383(9935). PMID: 24656685    Free PMC article.
Highly Cited.
A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Arvydas Laurinavicius, Benoit Plancoulaine, +8 authors, Catherine Bor.
Breast Cancer Res, 2014 Apr 09; 16(2). PMID: 24708745    Free PMC article.
Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients - a retrospective study of clinical and tumor characteristics.
Nikola Besic, Nika Satej, +4 authors, Rok Petric.
BMC Cancer, 2014 Apr 30; 14. PMID: 24774412    Free PMC article.
Superficial scrapings from breast tumors is a source for biobanking and research purposes.
Ran Ma, Irma Fredriksson, +4 authors, Johan Hartman.
Lab Invest, 2014 Apr 30; 94(7). PMID: 24776644
In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement.
Ildiko Illyes, Anna-Maria Tokes, +8 authors, Janina Kulka.
Virchows Arch, 2014 May 09; 465(1). PMID: 24809673
Relationship between chemotherapy and prognosis in different subtypes of node-negative breast cancer.
Xia Liu, Yong Guan, +5 authors, Yun Niu.
Tumour Biol, 2014 May 28; 35(9). PMID: 24863944
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Olivia Pagani, Meredith M Regan, +32 authors, International Breast Cancer Study Group.
N Engl J Med, 2014 Jun 03; 371(2). PMID: 24881463    Free PMC article.
Highly Cited.
Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma.
Ruilian Xie, Yanru Wang, +4 authors, Xiaoxiang Guan.
Cancer Biother Radiopharm, 2014 Jun 03; 29(5). PMID: 24885919    Free PMC article.
A single nucleotide polymorphism in PIK3CA gene is inversely associated with P53 protein expression in breast cancer.
Bo Pang, Shi-Peng Sun, +5 authors, Gui-Jian Liu.
Med Oncol, 2014 Jun 09; 31(7). PMID: 24908061
Modern therapeutic concepts of early breast cancer.
Michael Gnant.
Breast Care (Basel), 2014 Jun 20; 9(2). PMID: 24944549    Free PMC article.
Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial.
Toralf Reimer, Steffi Hartmann, Angrit Stachs, Bernd Gerber.
Breast Care (Basel), 2014 Jun 20; 9(2). PMID: 24944550    Free PMC article.
Review.
The human epidermal growth factor receptor 2 screening tests for breast cancer suggested by the new updated recommendation of the american society of clinical oncology/college of american pathologists will involve a rise of the in-situ hybridization tests for the European laboratories of pathology.
Christian Garbar, Aude-Marie Savoye, +2 authors, Hervé Curé.
ISRN Oncol, 2014 Jun 20; 2014. PMID: 24944830    Free PMC article.
A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status.
Songjie Shen, Qiang Sun, +5 authors, Yidong Zhou.
PLoS One, 2014 Jun 20; 9(6). PMID: 24945253    Free PMC article.
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes.
Patrick Maisonneuve, Davide Disalvatore, +10 authors, Aron Goldhirsch.
Breast Cancer Res, 2014 Jun 22; 16(3). PMID: 24951027    Free PMC article.
Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.
Maria Vittoria Dieci, Enrico Orvieto, +2 authors, Valentina Guarneri.
Oncologist, 2014 Jun 28; 19(8). PMID: 24969162    Free PMC article.
A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers.
Nhan T Nguyen, Julie A Vendrell, +8 authors, Pascale A Cohen.
Mol Oncol, 2014 Jun 29; 8(8). PMID: 24973012    Free PMC article.
Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.
Mieke Van Bockstal, Kathleen Lambein, +6 authors, Louis Libbrecht.
Virchows Arch, 2014 Jun 30; 465(3). PMID: 24973889
BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy.
Beata Biesaga, Joanna Niemiec, Marek Ziobro.
J Cancer Res Clin Oncol, 2014 Jul 10; 140(12). PMID: 25005788    Free PMC article.
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients.
Bjørnar Gilje, Oddmund Nordgård, +4 authors, Bjørn Naume.
BMC Cancer, 2014 Jul 16; 14. PMID: 25023626    Free PMC article.
Predictors of recurrence in breast cancer subtypes with negative lymph node in a Chinese population.
Xia Liu, Yong Guan, +4 authors, Yun Niu.
Int J Clin Exp Pathol, 2014 Jul 18; 7(6). PMID: 25031741    Free PMC article.
Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status.
Aleix Prat, Cristina Cruz, +3 authors, Judith Balmaña.
Breast Cancer Res Treat, 2014 Jul 23; 147(1). PMID: 25048467    Free PMC article.
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.
Laura Zanotti, Alberto Bottini, +2 authors, Maria Rosa Cappelletti.
Tumour Biol, 2014 Jul 23; 35(9). PMID: 25048969
Review.
Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404.
Tadahiko Shien, Hiroji Iwata, +8 authors, Haruhiko Fukuda.
Cancer Chemother Pharmacol, 2014 Jul 25; 74(3). PMID: 25055938    Free PMC article.
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer.
Yoshiya Horimoto, Atsushi Arakawa, +7 authors, Mitsue Saito.
BMC Cancer, 2014 Jul 31; 14. PMID: 25073969    Free PMC article.
Classification of patients with breast cancer according to Nottingham prognostic index highlights significant differences in immunohistochemical marker expression.
Fisnik Kurshumliu, Lumturije Gashi-Luci, +2 authors, Ugur Gozalan.
World J Surg Oncol, 2014 Aug 02; 12. PMID: 25082024    Free PMC article.
Breast radiotherapy (RT) using tangential fields (TgF): a prospective evaluation of the dose distribution in the sentinel lymph node (SLN) area as determined intraoperatively by clip placement.
Yazid Belkacemi, Veronique Bigorie, +8 authors, Romain Bosc.
Ann Surg Oncol, 2014 Aug 07; 21(12). PMID: 25096388    Free PMC article.
A Brief History of Breast Cancer: Part II - Evolution of surgical pathology.
Ritu Lakhtakia, Roshan F Chinoy.
Sultan Qaboos Univ Med J, 2014 Aug 07; 14(3). PMID: 25097765    Free PMC article.
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).
Pat Whitworth, Lisette Stork-Sloots, +11 authors, Peter D Beitsch.
Ann Surg Oncol, 2014 Aug 08; 21(10). PMID: 25099655    Free PMC article.
Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.
Rebecca Moffat, Uwe Güth.
Breast Cancer (Dove Med Press), 2014 Aug 13; 6. PMID: 25114587    Free PMC article.
Review.
Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer.
B Jaime Jans, M Nicolás Escudero, +3 authors, A Mauricio Camus.
Ecancermedicalscience, 2014 Aug 13; 8. PMID: 25114720    Free PMC article.
Biological subtypes of breast cancer: Prognostic and therapeutic implications.
Ozlem Yersal, Sabri Barutca.
World J Clin Oncol, 2014 Aug 13; 5(3). PMID: 25114856    Free PMC article.
Highly Cited. Review.
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases.
Clelia Madeddu, Giulia Gramignano, +2 authors, Antonio Macciò.
Oncol Lett, 2014 Aug 15; 8(3). PMID: 25120706    Free PMC article.
Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Aleix Prat, Lisa A Carey, +6 authors, José Baselga.
J Natl Cancer Inst, 2014 Aug 21; 106(8). PMID: 25139534    Free PMC article.
Highly Cited.
[18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancer.
Sung Gwe Ahn, Minkyung Lee, +6 authors, Joon Jeong.
PLoS One, 2014 Aug 29; 9(8). PMID: 25167062    Free PMC article.
Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study.
Yu Zong, Li Zhu, +7 authors, Kunwei Shen.
PLoS One, 2014 Aug 30; 9(8). PMID: 25170613    Free PMC article.
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
R I Cordo Russo, W Béguelin, +10 authors, P V Elizalde.
Oncogene, 2014 Sep 02; 34(26). PMID: 25174405
Chemotherapy in early breast cancer: when, how and which one?
Marcus Schmidt.
Breast Care (Basel), 2014 Sep 02; 9(3). PMID: 25177256    Free PMC article.
Review.
Efficiency of a preoperative axillary ultrasound and fine-needle aspiration cytology to detect patients with extensive axillary lymph node involvement.
Isabella Castellano, Cristina Deambrogio, +7 authors, Anna Sapino.
PLoS One, 2014 Sep 11; 9(9). PMID: 25207643    Free PMC article.
Relationship of clinical and pathologic nodal staging in locally advanced breast cancer: current controversies in daily practice?
Francesca De Felice, Daniela Musio, +2 authors, Vincenzo Tombolini.
J Clin Med Res, 2014 Sep 24; 6(6). PMID: 25247013    Free PMC article.
Review.
Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis.
Xiao-song Chen, Ying Yuan, +3 authors, Kun-wei Shen.
PLoS One, 2014 Sep 24; 9(9). PMID: 25247558    Free PMC article.
Surgical treatment of breast cancer in patients aged 80 years or older--how much is enough?
Nikola Besic, Hana Besic, +5 authors, Andraz Perhavec.
BMC Cancer, 2014 Sep 25; 14. PMID: 25249067    Free PMC article.
Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification.
A García Fernández, C Chabrera, +11 authors, N Giménez.
Clin Transl Oncol, 2014 Oct 02; 17(3). PMID: 25270605
A study comparing two consecutive historical periods in breast cancer with a focus on surgical treatment, loco-regional recurrence, distant metastases and mortality.
A García-Fernández, C Chabrera, +11 authors, N Gimenez.
Clin Transl Oncol, 2014 Oct 02; 17(4). PMID: 25270606
Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.
Monica J Engstrøm, Signe Opdahl, +2 authors, Anna M Bofin.
Histopathology, 2014 Oct 07; 66(3). PMID: 25283075    Free PMC article.
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype.
Immacolata Capasso, Emanuela Esposito, +13 authors, Giuseppe D'Aiuto.
Diabetol Metab Syndr, 2014 Oct 07; 6(1). PMID: 25285159    Free PMC article.
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.
Mark Kriegsmann, Volker Endris, +8 authors, Wilko Weichert.
Oncotarget, 2014 Oct 10; 5(20). PMID: 25296970    Free PMC article.
Breast cancer therapy planning - a novel support concept for a sequential decision making problem.
Alexander Scherrer, Ilka Schwidde, +3 authors, Karl-Heinz Küfer.
Health Care Manag Sci, 2014 Oct 16; 18(3). PMID: 25315184
Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method.
Anna Sapino, Francesca Maletta, +16 authors, Caterina Marchiò.
Oncologist, 2014 Oct 18; 19(11). PMID: 25323485    Free PMC article.
Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status.
Sigrid Hatse, Barbara Brouwers, +4 authors, Hans Wildiers.
PLoS One, 2014 Oct 22; 9(10). PMID: 25333486    Free PMC article.
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.
Alan P Venook, Maria E Arcila, +15 authors, Marian L Birkeland.
J Natl Compr Canc Netw, 2014 Nov 02; 12(11). PMID: 25361808    Free PMC article.
Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer.
Kristina E Aaltonen, Ann H Rosendahl, +3 authors, Mårten Fernö.
BMC Cancer, 2014 Nov 05; 14. PMID: 25362932    Free PMC article.
Is axillary lymph node clearance required in node-positive breast cancer?
Nigel J Bundred, Nicola L P Barnes, Emiel Rutgers, Mila Donker.
Nat Rev Clin Oncol, 2014 Nov 05; 12(1). PMID: 25367714
Review.
Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays.
Gøril Knutsvik, Ingunn M Stefansson, +4 authors, Lars A Akslen.
PLoS One, 2014 Nov 07; 9(11). PMID: 25375149    Free PMC article.
Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Ariadna Tibau, Laura López-Vilaró, +9 authors, Daniel Escuin.
Neoplasia, 2014 Nov 08; 16(10). PMID: 25379022    Free PMC article.
[Not Available].
David Krug.
Strahlenther Onkol, 2014 Nov 14; 190(10). PMID: 25392872
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study.
D Balmativola, C Marchiò, +26 authors, A Sapino.
Breast Cancer Res Treat, 2014 Nov 15; 148(3). PMID: 25395316    Free PMC article.
Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.
Jingyu Zhou, Yi Yan, +5 authors, Lili Tang.
Saudi Med J, 2014 Nov 17; 35(11). PMID: 25399208    Free PMC article.
Association between molecular subtypes and lymph node status in invasive breast cancer.
Chengshuai Si, Yiting Jin, Hongying Wang, Qiang Zou.
Int J Clin Exp Pathol, 2014 Nov 18; 7(10). PMID: 25400761    Free PMC article.
Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
Debora Fumagalli, Alexis Blanchet-Cohen, +13 authors, Benjamin Haibe-Kains.
BMC Genomics, 2014 Nov 22; 15. PMID: 25412710    Free PMC article.
HPV infection and triple-negative breast cancers: an Italian case-control study.
Andrea Fausto Piana, Giovanni Sotgiu, +3 authors, Maria Rosaria De Miglio.
Virol J, 2014 Nov 22; 11. PMID: 25413873    Free PMC article.
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.
Y Horimoto, A Arakawa, +9 authors, M Saito.
Br J Cancer, 2014 Nov 26; 112(2). PMID: 25422910    Free PMC article.
Effectiveness of adjuvant trastuzumab in daily clinical practice.
Erika Matos, Branko Zakotnik, Cvetka Grasic Kuhar.
Radiol Oncol, 2014 Dec 02; 48(4). PMID: 25435855    Free PMC article.
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence.
Amalia M Issa, Vivek S Chaudhari, Gary E Marchant.
Expert Rev Mol Diagn, 2014 Dec 06; 15(2). PMID: 25479414    Free PMC article.
Review.
Making breast cancer molecular subtypes robust?
Johan Staaf, Markus Ringnér.
J Natl Cancer Inst, 2014 Dec 07; 107(1). PMID: 25479803    Free PMC article.
Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
San-Gang Wu, Jia-Yuan Sun, +6 authors, Zhen-Yu He.
Radiat Oncol, 2014 Dec 17; 9. PMID: 25511525    Free PMC article.
A survey of etiologic hypotheses among testicular cancer researchers.
A Stang, B Trabert, +4 authors, K A McGlynn.
Andrology, 2014 Dec 30; 3(1). PMID: 25538016    Free PMC article.
Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterparts.
Christine Staudigl, Michaela Bartova, +5 authors, Muy-Kheng M Tea.
Tumour Biol, 2014 Dec 30; 36(5). PMID: 25544709
Unique features of young age breast cancer and its management.
Han-Byoel Lee, Wonshik Han.
J Breast Cancer, 2014 Dec 31; 17(4). PMID: 25548576    Free PMC article.
Review.
Meeting highlights: the first korean breast cancer treatment consensus conference.
Airi Han, Kyoung Eun Lee, +6 authors, Korean Breast Cancer Treatment Consensus Conference Panelists.
J Breast Cancer, 2014 Dec 31; 17(4). PMID: 25548577    Free PMC article.
Review.
Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.
Vanessa B Sheppard, Suzanne C O'Neill, +3 authors, Claudine Isaacs.
Clin Breast Cancer, 2015 Jan 04; 15(2). PMID: 25555816    Free PMC article.
Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes.
Misato Iizuka, Yoko Nakanishi, +8 authors, Shinobu Masuda.
Cancer Sci, 2015 Jan 06; 106(3). PMID: 25556893    Free PMC article.
Intrinsic cancer subtypes--next steps into personalized medicine.
Cristina Santos, Rebeca Sanz-Pamplona, +6 authors, Ramon Salazar.
Cell Oncol (Dordr), 2015 Jan 15; 38(1). PMID: 25586691
Review.
Pattern of metastasis and outcome in patients with breast cancer.
L Gerratana, V Fanotto, +4 authors, F Puglisi.
Clin Exp Metastasis, 2015 Jan 30; 32(2). PMID: 25630269
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.
Gul Alco, Atilla Bozdogan, +8 authors, Vahit Ozmen.
Oncol Lett, 2015 Feb 11; 9(3). PMID: 25663855    Free PMC article.
Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes.
San-Gang Wu, Fang Peng, +6 authors, Zhen-Yu He.
J Cancer, 2015 Feb 11; 6(3). PMID: 25663944    Free PMC article.
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.
Hiroyasu Yamshiro, Hiroji Iwata, +18 authors, Masakazu Toi.
Int J Clin Oncol, 2015 Feb 11; 20(4). PMID: 25666483
Management of locally advanced breast cancer-perspectives and future directions.
Konstantinos Tryfonidis, Elzbieta Senkus, Maria J Cardoso, Fatima Cardoso.
Nat Rev Clin Oncol, 2015 Feb 11; 12(3). PMID: 25668732
Review.
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.
Flavio Crippa, Roberto Agresti, +13 authors, Filippo de Braud.
Eur J Nucl Med Mol Imaging, 2015 Feb 13; 42(6). PMID: 25673053
Minimising unnecessary mastectomies in a predominantly Chinese community.
Mona P Tan, Nadya Y Sitoh, Yih Y Sitoh.
Int J Surg Oncol, 2015 Feb 19; 2015. PMID: 25692037    Free PMC article.
An international study to increase concordance in Ki67 scoring.
Mei-Yin C Polley, Samuel C Y Leung, +28 authors, Torsten O Nielsen.
Mod Pathol, 2015 Feb 24; 28(6). PMID: 25698062
Highly Cited.
Co-Expression of p16, Ki67 and COX-2 Is Associated with Basal Phenotype in High-Grade Ductal Carcinoma In Situ of the Breast.
Amanda Arantes Perez, Débora Balabram, +2 authors, Helenice Gobbi.
J Histochem Cytochem, 2015 Feb 26; 63(6). PMID: 25711229    Free PMC article.
Systemic treatment with capecitabine as maintenance therapy in patients with recurring or metastatic breast cancer: experience in the Oncology Hospital, National Medical Center Siglo XXI, Mexican Social Security Institute.
Manuel Segura-González, Miguel Quintana-Quintana.
Med Oncol, 2015 Feb 28; 32(4). PMID: 25720523
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.
Raúl Rincón, Ion Cristóbal, +10 authors, Federico Rojo.
Oncotarget, 2015 Mar 03; 6(6). PMID: 25726524    Free PMC article.
Ovarian stimulation in patients with breast cancer.
Elkin Muñoz, Naira González, +2 authors, Juan A García Velasco.
Ecancermedicalscience, 2015 Mar 03; 9. PMID: 25729417    Free PMC article.
Fertility preservation and breast cancer: a review.
María de Pedro, Borja Otero, Belén Martín.
Ecancermedicalscience, 2015 Mar 03; 9. PMID: 25729416    Free PMC article.
Review.
Very low mammographic breast density predicts poorer outcome in patients with invasive breast cancer.
Amro Masarwah, Päivi Auvinen, +6 authors, Ritva Vanninen.
Eur Radiol, 2015 Mar 05; 25(7). PMID: 25735512
One-Year Neoadjuvant Endocrine Therapy in Breast Cancer.
Orsolya Rusz, András Vörös, +6 authors, Zsuzsanna Kahán.
Pathol Oncol Res, 2015 Mar 11; 21(4). PMID: 25753983
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.
Ines Vaz-Luis, Melissa E Hughes, +7 authors, Nancy U Lin.
Cancer, 2015 Mar 12; 121(12). PMID: 25757412    Free PMC article.
Guideline conformity treatment in young women with early-onset breast cancer in Germany.
Telja Pursche, Marianne Hedderich, +5 authors, Dorothea Fischer.
Breast Care (Basel), 2015 Mar 12; 9(5). PMID: 25759616    Free PMC article.
Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients.
Ibrahim Turker, Ulku Y Arslan, +10 authors, Nurullah Zengin.
Breast Care (Basel), 2015 Mar 12; 9(6). PMID: 25759625    Free PMC article.
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index.
Cristina Molinari, Paola Clauser, +5 authors, Massimo Bazzocchi.
Radiol Med, 2015 Mar 18; 120(10). PMID: 25776017
Ki67--no evidence for its use in node-positive breast cancer.
Fabrice Andre, Monica Arnedos, +2 authors, Suzette Delaloge.
Nat Rev Clin Oncol, 2015 Mar 18; 12(5). PMID: 25781576
Review.
Breast cancer under age 40: a different approach.
D Ribnikar, J M Ribeiro, +6 authors, F Cardoso.
Curr Treat Options Oncol, 2015 Mar 23; 16(4). PMID: 25796377
Review.
Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast.
Li Wang, Wei Zhang, +6 authors, Yun Niu.
Tumour Biol, 2015 Mar 25; 36(4). PMID: 25801239
Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer.
Jiang-Hua Qiao, De-Chuang Jiao, +2 authors, Zhen-Zhen Liu.
Tumour Biol, 2015 Apr 08; 36(9). PMID: 25846735
Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
S Sun, X Liang, +8 authors, D Pang.
Br J Cancer, 2015 Apr 14; 112(8). PMID: 25867275    Free PMC article.
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.
Francisco Beca, Miguel Pereira, +2 authors, Fernando Schmitt.
BMC Cancer, 2015 Apr 17; 15. PMID: 25879784    Free PMC article.
Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.
San-Gang Wu, Jia-Yuan Sun, +5 authors, Zhen-Yu He.
BMC Cancer, 2015 Apr 17; 15. PMID: 25880737    Free PMC article.
Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
Li-Chen Tang, Xi Jin, +4 authors, Gen-Hong Di.
BMC Cancer, 2015 Apr 18; 15. PMID: 25885213    Free PMC article.
Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study.
Zsuzsanna Varga, Estelle Cassoly, +6 authors, Thomas Ruhstaller.
PLoS One, 2015 Apr 18; 10(4). PMID: 25885288    Free PMC article.
Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers.
Kristina P Sørensen, Mads Thomassen, +5 authors, Torben A Kruse.
Breast Cancer Res, 2015 Apr 19; 17. PMID: 25887545    Free PMC article.
Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
Tatiana Kempowsky-Hamon, Carine Valle, +12 authors, Véronique Anton-Leberre.
BMC Med Genomics, 2015 Apr 19; 8. PMID: 25888889    Free PMC article.
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study.
Tímea Tőkés, Gyöngyvér Szentmártoni, +7 authors, Magdolna Dank.
Croat Med J, 2015 Apr 22; 56(2). PMID: 25891872    Free PMC article.
A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Henrik Frithiof, Charlotte Welinder, +2 authors, Kristina Aaltonen.
J Transl Med, 2015 Apr 22; 13. PMID: 25896421    Free PMC article.
Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.
Balazs I Bodai, Phillip Tuso.
Perm J, 2015 Apr 23; 19(2). PMID: 25902343    Free PMC article.
Review.
Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
An-qi Li, Shu-ling Zhou, +4 authors, Wen-tao Yang.
PLoS One, 2015 May 06; 10(5). PMID: 25938238    Free PMC article.
Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.
Giovanna Masci, Michele Caruso, +13 authors, Armando Santoro.
Oncologist, 2015 May 08; 20(6). PMID: 25948676    Free PMC article.
Breast cancer in young women in southern Tunisia: Anatomical study and clinical prognostic factors: About a series of 83 patients.
Mouna Kallel, Fatma Elloumi, +5 authors, Jamel Daoud.
Rep Pract Oncol Radiother, 2015 May 08; 20(3). PMID: 25949218    Free PMC article.
Review.
Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.
San-Gang Wu, Yan Wang, +4 authors, Zhen-Yu He.
Am J Cancer Res, 2015 May 15; 5(2). PMID: 25973321    Free PMC article.
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.
Charlotte K Y Ng, Luciano G Martelotto, +20 authors, Jorge S Reis-Filho.
Genome Biol, 2015 May 23; 16. PMID: 25994018    Free PMC article.
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
Laura Evangelista, Anna Rita Cervino, +6 authors, Pierfranco Conte.
Eur J Nucl Med Mol Imaging, 2015 May 31; 42(11). PMID: 26025244
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, +6 authors, Vincenzo Adamo.
PLoS One, 2015 Jun 04; 10(6). PMID: 26039245    Free PMC article.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
S Gillessen, A Omlin, +41 authors, B Tombal.
Ann Oncol, 2015 Jun 05; 26(8). PMID: 26041764    Free PMC article.
Highly Cited.
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).
Vito Amoroso, Daniele Generali, +30 authors, Alberto Bottini.
J Natl Cancer Inst Monogr, 2015 Jun 13; 2015(51). PMID: 26063896    Free PMC article.
Clinical utility of exemestane in the treatment of breast cancer.
Giorgia Zucchini, Elena Geuna, +3 authors, Filippo Montemurro.
Int J Womens Health, 2015 Jun 13; 7. PMID: 26064072    Free PMC article.
Review.
Lipid-rich carcinoma of male breast in Chinese: a case report and literature review.
Shujian Xu, Cui Zhao, +5 authors, Zhenlin Yang.
Int J Clin Exp Med, 2015 Jun 13; 8(3). PMID: 26064365    Free PMC article.
Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.
Gregory Katz, Olivier Romano, +7 authors, Rémy Salmon.
PLoS One, 2015 Jun 19; 10(6). PMID: 26086912    Free PMC article.
Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.
Xia-Ying Kuang, Li Chen, +7 authors, Zhi-Ming Shao.
Oncotarget, 2015 Jun 19; 6(26). PMID: 26087399    Free PMC article.
Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.
Matteo Lambertini, Arlindo R Ferreira, +16 authors, Lucia Del Mastro.
Oncologist, 2015 Jun 24; 20(8). PMID: 26099741    Free PMC article.
Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice.
S Antolín-Novoa, E Blanco-Campanario, +7 authors, SmallHER Study Group.
Clin Transl Oncol, 2015 Jun 25; 17(11). PMID: 26103952
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
Joseph Gligorov, Xavier B Pivot, +11 authors, Francilian Breast Intergroup.
Oncologist, 2015 Jun 27; 20(8). PMID: 26112003    Free PMC article.
IVF for fertility preservation in breast cancer patients--efficacy and safety issues.
M Shapira, H Raanani, D Meirow.
J Assist Reprod Genet, 2015 Jul 02; 32(8). PMID: 26126877    Free PMC article.
Review.
One-Step Nucleic Acid Amplification in Breast Cancer Sentinel Lymph Node: A Single Institutional Experience and a Short Review.
Tatiana Brambilla, Barbara Fiamengo, +7 authors, Luca Di Tommaso.
Front Med (Lausanne), 2015 Jul 02; 2. PMID: 26131451    Free PMC article.
Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013: A Retrospective Study.
Wen Si, Ying Li, +6 authors, Junlan Yang.
Medicine (Baltimore), 2015 Jul 02; 94(26). PMID: 26131834    Free PMC article.
Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
S Subramaniam, N Bhoo-Pathy, +6 authors, C H Yip.
World J Surg, 2015 Jul 04; 39(10). PMID: 26138872
Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?
Anna Rachelle Mislang, Laura Biganzoli.
Cancers (Basel), 2015 Jul 08; 7(3). PMID: 26151681    Free PMC article.
Review.
Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013.
Hyo Jung Ahn, Soo Jin Jung, +2 authors, Hye-Kyoung Yoon.
J Breast Cancer, 2015 Jul 15; 18(2). PMID: 26155291    Free PMC article.
Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative (18)F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer.
Young Hwan Kim, Hai-Jeon Yoon, Yemi Kim, Bom Sahn Kim.
J Breast Cancer, 2015 Jul 15; 18(2). PMID: 26155294    Free PMC article.
The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer.
Hiroaki Inoue, Akira Hirano, +7 authors, Tadao Shimizu.
Springerplus, 2015 Jul 15; 4. PMID: 26155442    Free PMC article.
Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.
Rumiko Tashima, Reiki Nishimura, +6 authors, Nobuyuki Arima.
PLoS One, 2015 Jul 16; 10(7). PMID: 26177501    Free PMC article.
Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation.
Zachary Medress, Melanie Hayden Gephart.
Cureus, 2015 Jul 17; 7(1). PMID: 26180670    Free PMC article.
Review.
Autophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathway.
Christian Garbar, Corinne Mascaux, +5 authors, Armand Bensussan.
Int J Clin Exp Pathol, 2015 Jul 21; 8(5). PMID: 26191126    Free PMC article.
Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients.
Hideo Shimizu, Yoshiya Horimoto, +14 authors, Mitsue Saito.
Breast Care (Basel), 2015 Jul 22; 10(2). PMID: 26195940    Free PMC article.
St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.
Michael Gnant, Christoph Thomssen, Nadia Harbeck.
Breast Care (Basel), 2015 Jul 22; 10(2). PMID: 26195941    Free PMC article.
Review.
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?
Wilbert Zwart, Huub Terra, Sabine C Linn, Sanne B Schagen.
Nat Rev Clin Oncol, 2015 Jul 22; 12(10). PMID: 26196252
Review.
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.
Otto Metzger Filho, Anita Giobbie-Hurder, +12 authors, Aron Goldhirsch.
J Clin Oncol, 2015 Jul 29; 33(25). PMID: 26215945    Free PMC article.
Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa).
Pier Vitale Nuzzo, Alessandra Rubagotti, +6 authors, Francesco Boccardo.
Int J Mol Sci, 2015 Aug 01; 16(8). PMID: 26225965    Free PMC article.
Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.
Fanny Le Du, Ana M Gonzalez-Angulo, +3 authors, Naoto T Ueno.
Clin Breast Cancer, 2015 Aug 04; 15(6). PMID: 26233757    Free PMC article.
Electrochemotherapy in the Treatment of Cutaneous Metastases from Breast Cancer: A Multicenter Cohort Analysis.
C Cabula, L G Campana, +14 authors, R Agresti.
Ann Surg Oncol, 2015 Aug 06; 22 Suppl 3. PMID: 26242370    Free PMC article.
p27(Kip1) and Ser10-phosphorylated p27(Kip1) in breast cancer: clinical significance and expression.
Wei Song, Ruilian Xie, +6 authors, Xiaoxiang Guan.
Onco Targets Ther, 2015 Aug 06; 8. PMID: 26244023    Free PMC article.
Carcinoma in situ to invasive breast cancer.
Carolien H M van Deurzen, John A Foekens.
Oncoscience, 2015 Aug 06; 2(6). PMID: 26244162    Free PMC article.
Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.
Jon Lidfeldt, Pär-Ola Bendahl, +3 authors, Mattias Belting.
PLoS One, 2015 Aug 06; 10(8). PMID: 26244666    Free PMC article.
The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study.
Eva Culakova, Marek S Poniewierski, +3 authors, Gary H Lyman.
Springerplus, 2015 Aug 08; 4. PMID: 26251780    Free PMC article.
Predicting benefit of endocrine therapy for early breast cancer.
Meredith M Regan.
Breast, 2015 Aug 10; 24 Suppl 2. PMID: 26255197    Free PMC article.
Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.
D Merino, S W Lok, J E Visvader, G J Lindeman.
Oncogene, 2015 Aug 11; 35(15). PMID: 26257067
Review.
Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.
A Kümmel, S Kümmel, +9 authors, B Ataseven.
Geburtshilfe Frauenheilkd, 2015 Aug 11; 75(7). PMID: 26257408    Free PMC article.
Unexpected features of breast cancer subtype.
Ye-huan Liu, Ou-chen Wang, +4 authors, Xiao-hua Zhang.
World J Surg Oncol, 2015 Aug 15; 13. PMID: 26271634    Free PMC article.
Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer.
Hyojin Kim, Kyung-Hun Lee, +7 authors, Han Suk Ryu.
Virchows Arch, 2015 Aug 19; 467(5). PMID: 26280894
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
Noemi Perez-Janices, Idoia Blanco-Luquin, +13 authors, David Guerrero-Setas.
Oncotarget, 2015 Aug 19; 6(27). PMID: 26284587    Free PMC article.
Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
Jee Suk Chang, Jeongshim Lee, +7 authors, Yong Bae Kim.
Medicine (Baltimore), 2015 Aug 20; 94(33). PMID: 26287410    Free PMC article.
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Brett Wallden, James Storhoff, +16 authors, Joel S Parker.
BMC Med Genomics, 2015 Aug 25; 8. PMID: 26297356    Free PMC article.
Highly Cited.
Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients.
Yue Zhao, Xiaoqiu Dong, +2 authors, Dongwei Zhang.
Transl Oncol, 2015 Aug 28; 8(4). PMID: 26310372    Free PMC article.
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer.
David Riseberg.
Clin Med Insights Oncol, 2015 Sep 05; 9. PMID: 26339192    Free PMC article.
Review.
hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers.
Elena Lastraioli, Tiziano Lottini, +2 authors, Annarosa Arcangeli.
Biomed Res Int, 2015 Sep 05; 2015. PMID: 26339650    Free PMC article.
Review.
Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram.
Agnese Barnabei, Lidia Strigari, +4 authors, Francesco Torino.
Oncologist, 2015 Sep 06; 20(10). PMID: 26341758    Free PMC article.
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
M Dietel, K Jöhrens, +12 authors, I Anagnostopoulos.
Cancer Gene Ther, 2015 Sep 12; 22(9). PMID: 26358176
Review.
Prognostic effect analysis of molecular subtype on young breast cancer patients.
Hong-Liang Chen, Ang Ding, Fu-Wen Wang.
Chin J Cancer Res, 2015 Sep 12; 27(4). PMID: 26361413    Free PMC article.
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
Siker Kimbung, Anikó Kovács, +10 authors, Ingrid Hedenfalk.
Oncotarget, 2015 Sep 17; 6(32). PMID: 26375671    Free PMC article.
Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes.
Ilaria Cancarini, Vittorio Krogh, +8 authors, Sabina Sieri.
PLoS One, 2015 Sep 17; 10(9). PMID: 26376452    Free PMC article.
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.
L Rossi, E Laas, +6 authors, F Reyal.
Br J Cancer, 2015 Sep 18; 113(7). PMID: 26379080    Free PMC article.
The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation.
Bernhard Kötter, Benjamin Frey, +5 authors, Udo S Gaipl.
Radiat Oncol, 2015 Sep 19; 10. PMID: 26383236    Free PMC article.
BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
Charlene Kan, Junran Zhang.
Int J Radiat Oncol Biol Phys, 2015 Sep 19; 93(2). PMID: 26383678    Free PMC article.
Review.
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.
E Munzone, A Giobbie-Hurder, +13 authors, International Breast Cancer Study Group and the BIG 1-98 Collaborative Group.
Ann Oncol, 2015 Sep 21; 26(12). PMID: 26387144    Free PMC article.
Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
Gerd Fastner, Cornelia Hauser-Kronberger, +7 authors, Felix Sedlmayer.
Strahlenther Onkol, 2015 Sep 26; 192(1). PMID: 26403912
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria.
Isabelle de Mascarel, Marc Debled, +8 authors, Gaëtan MacGrogan.
Springerplus, 2015 Sep 26; 4. PMID: 26405647    Free PMC article.
Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era.
Jinli Ma, Rui Jiang, +6 authors, Zhimin Shao.
Oncotarget, 2015 Sep 30; 6(34). PMID: 26416456    Free PMC article.
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups.
Katharine Yao, Robert Goldschmidt, +4 authors, Massimo Cristofanilli.
Breast Cancer Res Treat, 2015 Oct 02; 154(1). PMID: 26424167    Free PMC article.
Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype.
Xuezheng Sun, Hazel B Nichols, +3 authors, Melissa A Troester.
Cancer Causes Control, 2015 Oct 03; 26(12). PMID: 26428518    Free PMC article.
Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.
Ke-Da Yu, Yi-Zhou Jiang, Shuang Hao, Zhi-Ming Shao.
BMC Med, 2015 Oct 07; 13. PMID: 26437901    Free PMC article.
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.
Mohamed I Nounou, Fatema ElAmrawy, +3 authors, Hussaini Syed-Sha-Qhattal.
Breast Cancer (Auckl), 2015 Oct 16; 9(Suppl 2). PMID: 26462242    Free PMC article.
Review.
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.
S Rahal, J M Boher, +12 authors, A Gonçalves.
BMC Cancer, 2015 Oct 16; 15. PMID: 26466893    Free PMC article.
Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.
Kokoro Kobayashi, Yoshinori Ito, +8 authors, Kiyohiko Hatake.
Surg Today, 2015 Oct 16; 46(7). PMID: 26467559
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem.
Fotinos-Ioannis D Dimitrakopoulos, Anastasia Kottorou, +2 authors, Haralabos P Kalofonos.
J Breast Cancer, 2015 Oct 17; 18(3). PMID: 26472970    Free PMC article.
Review.
The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients.
Nina G Egeland, Siri Lunde, +5 authors, Håvard Søiland.
Int J Mol Sci, 2015 Oct 17; 16(10). PMID: 26473850    Free PMC article.
Review.
A methodology for comprehensive breast cancer Ki67 labeling index with intra-tumor heterogeneity appraisal based on hexagonal tiling of digital image analysis data.
Benoit Plancoulaine, Aida Laurinaviciene, +5 authors, Arvydas Laurinavicius.
Virchows Arch, 2015 Oct 21;. PMID: 26481244
Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.
Suzanne C O'Neill, Claudine Isaacs, +8 authors, Arnold L Potosky.
J Natl Compr Canc Netw, 2015 Oct 21; 13(10). PMID: 26483061    Free PMC article.
St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.
M Soares, J Correia, M C Peleteiro, F Ferreira.
Tumour Biol, 2015 Oct 22; 37(3). PMID: 26486327
Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.
Jin Hong, Yan Mao, +7 authors, Kunwei Shen.
Tumour Biol, 2015 Oct 23; 37(3). PMID: 26490984
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Meredith M Regan, Olivia Pagani, +21 authors, SOFT and TEXT Investigators and International Breast Cancer Study Group.
Breast Cancer Res Treat, 2015 Oct 24; 154(2). PMID: 26493064    Free PMC article.
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype.
Eleanor F Need, Luke A Selth, +8 authors, Grant Buchanan.
BMC Cancer, 2015 Oct 27; 15. PMID: 26498662    Free PMC article.
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.
Sylvain Ladoire, Frédérique Penault-Llorca, +17 authors, Guido Kroemer.
Autophagy, 2015 Oct 29; 11(10). PMID: 26506894    Free PMC article.
Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.
Jee Ye Kim, Hyung Seok Park, +3 authors, Seung Il Kim.
Medicine (Baltimore), 2015 Oct 30; 94(43). PMID: 26512562    Free PMC article.
Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
Ruoxi Hong, Zhen Dai, Wenjie Zhu, Binghe Xu.
PLoS One, 2015 Oct 30; 10(10). PMID: 26513258    Free PMC article.
Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
Xiaosong Chen, Siji Zhu, +9 authors, Kunwei Shen.
BMC Cancer, 2015 Oct 31; 15. PMID: 26514283    Free PMC article.
High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer.
Yang Lin, Feng Lv, +5 authors, Li Fu.
J Cancer, 2015 Oct 31; 6(11). PMID: 26516361    Free PMC article.
Diffuse invasive breast carcinoma of no special type.
Tibor Tot.
Virchows Arch, 2015 Nov 02; 468(2). PMID: 26521062
Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis.
Haruo Ohtani, Kazuko Mori-Shiraishi, Morio Nakajima, Hamaichi Ueki.
Pathol Int, 2015 Nov 05; 65(12). PMID: 26530981    Free PMC article.
Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.
Xuezheng Sun, Hazel B Nichols, +5 authors, Melissa A Troester.
Cancer Epidemiol Biomarkers Prev, 2015 Nov 08; 25(1). PMID: 26545404    Free PMC article.
Androgen receptor status is highly conserved during tumor progression of breast cancer.
André Grogg, Mafalda Trippel, +6 authors, Coya Tapia.
BMC Cancer, 2015 Nov 11; 15. PMID: 26552477    Free PMC article.
Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population.
SeungTaek Lim, Se Ho Park, +3 authors, Young Jin Suh.
PLoS One, 2015 Nov 13; 10(11). PMID: 26562837    Free PMC article.
ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Batoul Kaabi, Ghania Belaaloui, +4 authors, Hocine Bounecer.
Pathol Oncol Res, 2015 Nov 14; 22(2). PMID: 26563278
Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer.
Fei Xie, Dongjie Zhang, +6 authors, Shan Wang.
World J Surg Oncol, 2015 Nov 21; 13. PMID: 26585236    Free PMC article.
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
Jeff Wang, Fumi Kato, +6 authors, Hiroki Shirato.
PLoS One, 2015 Nov 26; 10(11). PMID: 26600392    Free PMC article.
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.
Sandra M Swain, Raquel Nunes, +2 authors, Amy P Sing.
Adv Ther, 2015 Nov 28; 32(12). PMID: 26610382    Free PMC article.
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
Michael D Alvarado, Che Prasad, +5 authors, Christos J Markopoulos.
Adv Ther, 2015 Nov 28; 32(12). PMID: 26610383    Free PMC article.
Immune checkpoints: Cytotoxic T-lymphocyte antigen 4 and programmed cell death protein 1 in breast cancer surgery.
Agnieszka Kolacinska, Barbara Cebula-Obrzut, +7 authors, Piotr Smolewski.
Oncol Lett, 2015 Dec 02; 10(2). PMID: 26622629    Free PMC article.
Immunohistochemical evaluation of ROCK activation in invasive breast cancer.
Chih-Yi Hsu, Zee-Fen Chang, Hsiao-Hui Lee.
BMC Cancer, 2015 Dec 03; 15. PMID: 26626121    Free PMC article.
Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.
Zhen-Yu He, San-Gang Wu, +4 authors, Huan-Xin Lin.
Medicine (Baltimore), 2015 Dec 04; 94(48). PMID: 26632910    Free PMC article.
Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse.
Claudette Falato, Nicholas P Tobin, +3 authors, Theodoros Foukakis.
Mol Oncol, 2015 Dec 15; 10(4). PMID: 26651914    Free PMC article.
Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention.
Niamh Buckley, David Boyle, +9 authors, Manuel Salto-Tellez.
Oncotarget, 2015 Dec 15; 6(41). PMID: 26657114    Free PMC article.
Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
David Hicks, Patrizia Dell'Orto, +6 authors, Giuseppe Viale.
Appl Immunohistochem Mol Morphol, 2015 Dec 15; 25(5). PMID: 26657878    Free PMC article.
FGFR1 is an adverse outcome indicator for luminal A breast cancers.
Yu-Jie Shi, Julia Y S Tsang, +3 authors, Gary M Tse.
Oncotarget, 2015 Dec 18; 7(4). PMID: 26673008    Free PMC article.
Relapse profile of early breast cancer according to immunohistochemical subtypes: guidance for patient's follow up?
Nesrine Mejri, H Boussen, +3 authors, K Rahal.
Ther Adv Med Oncol, 2015 Dec 18; 7(3). PMID: 26674096    Free PMC article.
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Li-Xu Yan, Yan-Hui Liu, +11 authors, Jie Chen.
Int J Oncol, 2015 Dec 18; 48(2). PMID: 26676464    Free PMC article.
Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status.
Hiroko Yamashita.
World J Clin Oncol, 2015 Dec 18; 6(6). PMID: 26677435    Free PMC article.
Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group*.
Genet Med, 2015 Dec 19; 18(8). PMID: 26681310
Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer.
Mitsuhiro Hayashi, Yutaka Yamamoto, +5 authors, Hirotaka Iwase.
Medicine (Baltimore), 2015 Dec 20; 94(50). PMID: 26683963    Free PMC article.
Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.
Julia S Sisti, Laura C Collins, +3 authors, A Heather Eliassen.
Int J Cancer, 2015 Dec 20; 138(10). PMID: 26684063    Free PMC article.
The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings.
Beata Biesaga, Joanna Niemiec, +2 authors, Marek Ziobro.
Tumour Biol, 2015 Dec 22; 37(6). PMID: 26687650
The Modern Landscape of Endocrine Therapy for Premenopausal Women with Breast Cancer.
Lorenzo Rossi, Olivia Pagani.
Breast Care (Basel), 2015 Dec 22; 10(5). PMID: 26688677    Free PMC article.
Review.
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.
Emma H Allott, Stephanie M Cohen, +19 authors, Melissa A Troester.
Cancer Epidemiol Biomarkers Prev, 2015 Dec 30; 25(3). PMID: 26711328    Free PMC article.
Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas.
Rajyasree Emmadi, Emanuele Canestrari, +4 authors, Elizabeth Wiley.
PLoS One, 2015 Dec 31; 10(12). PMID: 26717565    Free PMC article.
Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor.
Masahiro Ohara, Etsushi Akimoto, +4 authors, Toshiyuki Itamoto.
Oncol Lett, 2016 Jan 02; 10(5). PMID: 26722327    Free PMC article.
Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast Cancer.
San-Gang Wu, Zhen-Yu He, +5 authors, Huan-Xin Lin.
J Cancer, 2016 Jan 02; 7(1). PMID: 26722358    Free PMC article.
Ki-67 is a prognostic marker for hormone receptor positive tumors.
M E Pérez-López, J García-Gómez, +3 authors, T García-Caballero.
Clin Transl Oncol, 2016 Jan 09; 18(10). PMID: 26742937    Free PMC article.
Efficacy of chemotherapy after hormone therapy for hormone receptor-positive metastatic breast cancer.
Ryutaro Mori, Yasuko Nagao.
SAGE Open Med, 2014 Jan 01; 2. PMID: 26770749    Free PMC article.
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.
Marco Colleoni, Zhuoxin Sun, +8 authors, Aron Goldhirsch.
J Clin Oncol, 2016 Jan 21; 34(9). PMID: 26786933    Free PMC article.
Highly Cited.
The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?
Yadong Sun, Xiaofeng Liu, +8 authors, Jiaxiang Wang.
Tumour Biol, 2016 Jan 23; 37(7). PMID: 26790445
Biologic subtype is a more important prognostic factor than nodal involvement in patients with stages I and II breast carcinoma.
Hyosun Kim, Jihyoung Cho, Sun Young Kwon, Sun Hee Kang.
Ann Surg Treat Res, 2016 Jan 23; 90(1). PMID: 26793686    Free PMC article.
Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009).
Nancy Krieger, Laurel A Habel, +5 authors, Stuart J Schnitt.
NPJ Breast Cancer, 2016 Jan 26; 1. PMID: 26807440    Free PMC article.
Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved.
Chiaki Saita, Risa Goto, +7 authors, Katsumasa Kuroi.
BMC Res Notes, 2016 Jan 28; 9. PMID: 26813772    Free PMC article.
Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
Arvydas Laurinavicius, Benoit Plancoulaine, +11 authors, Ian O Ellis.
Virchows Arch, 2016 Jan 29; 468(4). PMID: 26818835
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life.
Ornella Garrone, Filippo Montemurro, +10 authors, Marco Carlo Merlano.
Springerplus, 2016 Feb 03; 5. PMID: 26835238    Free PMC article.
Biomarkers of residual disease after neoadjuvant therapy for breast cancer.
Frederique Penault-Llorca, Nina Radosevic-Robin.
Nat Rev Clin Oncol, 2016 Feb 10; 13(8). PMID: 26856744
Review.
St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
A K Falck, A Röme, +4 authors, L Rydén.
Br J Surg, 2016 Feb 10; 103(5). PMID: 26856820    Free PMC article.
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Lyndsay N Harris, Nofisat Ismaila, +11 authors, American Society of Clinical Oncology.
J Clin Oncol, 2016 Feb 10; 34(10). PMID: 26858339    Free PMC article.
Highly Cited. Review.
Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives.
Meagan B Myers.
Pharmgenomics Pers Med, 2016 Feb 10; 9. PMID: 26858530    Free PMC article.
Review.
The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
P V Nuzzo, A Rubagotti, +3 authors, F Boccardo.
BMC Cancer, 2016 Feb 14; 16. PMID: 26872609    Free PMC article.
Interobserver Variability of Ki-67 Measurement in Breast Cancer.
Yul Ri Chung, Min Hye Jang, +3 authors, Korean Breast Pathology Ki-67 Study Group.
J Pathol Transl Med, 2016 Feb 16; 50(2). PMID: 26875758    Free PMC article.
Role of Combined Sentinel Lymph Node Biopsy and Axillary Node Sampling in Clinically Node-Negative Breast Cancer.
K J Edwards, M A Dordea, R French, V Kurup.
Indian J Surg, 2016 Feb 18; 77(6). PMID: 26884657    Free PMC article.
Role of patient and tumor characteristics in sentinel lymph node metastasis in patients with luminal early breast cancer: an observational study.
Nicla La Verde, Elena Biagioli, +8 authors, Giorgio Gherardi.
Springerplus, 2016 Feb 18; 5. PMID: 26885467    Free PMC article.
Evaluation of body esteem and mental health in patients with breast cancer after mastectomy.
Mohammad Heidari, Sara Shahbazi, Mansureh Ghodusi.
J Midlife Health, 2016 Feb 24; 6(4). PMID: 26903758    Free PMC article.
Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.
Maria Soares, Rita Ribeiro, +4 authors, Fernando Ferreira.
Oncotarget, 2016 Feb 26; 7(14). PMID: 26909614    Free PMC article.
Digital image analysis outperforms manual biomarker assessment in breast cancer.
Gustav Stålhammar, Nelson Fuentes Martinez, +9 authors, Johan Hartman.
Mod Pathol, 2016 Feb 27; 29(4). PMID: 26916072
Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.
Masaaki Kawai, Ai Tomotaki, +13 authors, Yutaka Tokuda.
Cancer Med, 2016 Mar 01; 5(6). PMID: 26923549    Free PMC article.
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Karolina Holm, Johan Staaf, +9 authors, Markus Ringnér.
Breast Cancer Res, 2016 Mar 01; 18(1). PMID: 26923702    Free PMC article.
A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Fangfang Zhong, Rui Bi, +3 authors, Ruohong Shui.
PLoS One, 2016 Mar 02; 11(2). PMID: 26928407    Free PMC article.
MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
Nerea Matamala, Maria Teresa Vargas, +8 authors, Javier Benítez.
Oncotarget, 2016 Mar 05; 7(15). PMID: 26933805    Free PMC article.
Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort.
Massimiliano D'Aiuto, Andrea Chirico, +9 authors, Antonio Giordano.
Cancer Biol Ther, 2016 Mar 05; 17(5). PMID: 26934127    Free PMC article.
A new histological therapeutic classification system to predict eradicated and residual lymph nodes in breast cancer after neoadjuvant chemotherapy.
Satoko Morohashi, Tadashi Yoshizawa, +7 authors, Hiroshi Kijima.
Oncol Rep, 2016 Mar 05; 35(5). PMID: 26935647    Free PMC article.
Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
Hyung Sun Kim, Seho Park, +6 authors, Byeong-Woo Park.
PLoS One, 2016 Mar 10; 11(3). PMID: 26954364    Free PMC article.
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.
Sura Aziz, Elisabeth Wik, +6 authors, Lars A Akslen.
PLoS One, 2016 Mar 10; 11(3). PMID: 26954367    Free PMC article.
The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
Anna Kuchel, Tim Robinson, +8 authors, Jeremy P Braybrooke.
Br J Cancer, 2016 Mar 10; 114(7). PMID: 26954715    Free PMC article.
Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer.
Sara Alkner, Pär-Ola Bendahl, +3 authors, Mårten Fernö.
PLoS One, 2016 Mar 10; 11(3). PMID: 26959415    Free PMC article.
The Genomic Landscape of Male Breast Cancers.
Salvatore Piscuoglio, Charlotte K Y Ng, +19 authors, Jorge S Reis-Filho.
Clin Cancer Res, 2016 Mar 11; 22(16). PMID: 26960396    Free PMC article.
Wilfully out of sight? A literature review on the effectiveness of cancer-related decision aids and implementation strategies.
Anne Herrmann, Elise Mansfield, +2 authors, Nicholas Zdenkowski.
BMC Med Inform Decis Mak, 2016 Mar 17; 16. PMID: 26979236    Free PMC article.
Review.
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
Shouping Xu, Peiyuan Wang, +6 authors, Da Pang.
Oncotarget, 2016 Mar 17; 7(15). PMID: 26980733    Free PMC article.
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment.
Niamh E Buckley, Claire Forde, +6 authors, Manuel Salto-Tellez.
Sci Rep, 2016 Mar 22; 6. PMID: 26996207    Free PMC article.
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Yayoi Adachi, Junko Ishiguro, +12 authors, Hiroji Iwata.
BMC Cancer, 2016 Mar 27; 16. PMID: 27015895    Free PMC article.
Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.
Tímea Tőkés, Anna-Mária Tőkés, +5 authors, Magdolna Dank.
Virchows Arch, 2016 Mar 31; 468(6). PMID: 27026269
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
Elena López-Knowles, Qiong Gao, +17 authors, POETIC trialists.
Breast Cancer Res, 2016 Apr 03; 18(1). PMID: 27036195    Free PMC article.
The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.
X Mao, C Gauche, +12 authors, S Fournel-Gigleux.
Oncogene, 2016 Apr 05; 35(38). PMID: 27041583
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.
Meredith M Regan, Prudence A Francis, +12 authors, Richard D Gelber.
J Clin Oncol, 2016 Apr 06; 34(19). PMID: 27044936    Free PMC article.
Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.
Jia-Yuan Sun, San-Gang Wu, +2 authors, Zhen-Yu He.
Onco Targets Ther, 2016 Apr 07; 9. PMID: 27051305    Free PMC article.
Manual Lymphatic Drainage after Subepidermal Tracer Injection Optimizes Results of Sentinel Lymph Node Labeling in Primary Breast Cancer.
Martin Sillem, Urban Bromberger, +3 authors, Sylvia Timme.
Breast Care (Basel), 2016 Apr 07; 11(1). PMID: 27051395    Free PMC article.
Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.
Thomas P Ahern, Deirdre P Cronin-Fenton, +4 authors, Ylva Hellberg.
Acta Oncol, 2016 Apr 09; 55(6). PMID: 27056567    Free PMC article.
Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy.
Chalanda N Evans, Noel T Brewer, +6 authors, Suzanne C O'Neill.
Breast Cancer Res Treat, 2016 Apr 10; 156(3). PMID: 27059031    Free PMC article.
CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ.
Michi Morita, Rin Yamaguchi, +9 authors, Hirohisa Yano.
Cancer Med, 2016 Apr 12; 5(7). PMID: 27061242    Free PMC article.
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.
Alberto Bouzón, Benigno Acea, +6 authors, Alejandra García.
Radiol Oncol, 2016 Apr 14; 50(1). PMID: 27069452    Free PMC article.
Evaluation of CCND1 amplification and CyclinD1 expression: diffuse and strong staining of CyclinD1 could have same predictive roles as CCND1 amplification in ER positive breast cancers.
Zhishuang Li, Jingjing Cui, +3 authors, Li Li.
Am J Transl Res, 2016 Apr 14; 8(1). PMID: 27069548    Free PMC article.
Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor.
Masahiro Ohara, Kazuo Matsuura, +5 authors, Toshiyuki Itamoto.
Mol Clin Oncol, 2016 Apr 14; 4(4). PMID: 27073684    Free PMC article.
Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey.
Vahit Ozmen, Ajlan Atasoy, +7 authors, Pinar Saip.
Cureus, 2016 Apr 16; 8(3). PMID: 27081583    Free PMC article.
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
E Martín-Sánchez, E Pernaut-Leza, +10 authors, D Guerrero-Setas.
Virchows Arch, 2016 Apr 22; 469(1). PMID: 27097811
Fat Grafting to the Breast, a Simple Procedure for a Very Complex Reconstruction.
Francisco Claro, Fernando Linhares Pereira, Aarão M Pinto-Neto.
Plast Reconstr Surg Glob Open, 2016 Apr 23; 4(1). PMID: 27104093    Free PMC article.
Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study.
Gyongyver Szentmartoni, Anna-Maria Tokes, +5 authors, Magdolna Dank.
Croat Med J, 2016 Apr 24; 57(2). PMID: 27106355    Free PMC article.
A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.
Zheng Feng, Hao Wen, +4 authors, Xiaohua Wu.
Sci Rep, 2016 May 04; 6. PMID: 27139372    Free PMC article.
Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.
Kathrin Halfter, Oliver Hoffmann, +6 authors, Barbara Mayer.
J Transl Med, 2016 May 05; 14(1). PMID: 27142386    Free PMC article.
Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People's Republic of China.
Ping Zhou, Yi-Zhou Jiang, +5 authors, Zhi-Ming Shao.
Onco Targets Ther, 2016 May 05; 9. PMID: 27143924    Free PMC article.
Prognostic and predictive value of Ki-67 in triple-negative breast cancer.
Wei Wang, Jiayi Wu, +9 authors, Li Zhu.
Oncotarget, 2016 May 05; 7(21). PMID: 27145269    Free PMC article.
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population.
Jiayu Wang, Die Sang, +9 authors, Qiao Li.
Medicine (Baltimore), 2016 May 07; 95(18). PMID: 27149453    Free PMC article.
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.
Sara Bustreo, Simona Osella-Abate, +6 authors, Isabella Castellano.
Breast Cancer Res Treat, 2016 May 09; 157(2). PMID: 27155668    Free PMC article.
A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Sea-Won Lee, Yeon-Joo Kim, +7 authors, Eun Sook Lee.
Medicine (Baltimore), 2016 May 14; 95(19). PMID: 27175630    Free PMC article.
Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: association with histopathological features and subtypes.
Yunju Kim, Kyounglan Ko, +4 authors, Boram Park.
Br J Radiol, 2016 May 21; 89(1063). PMID: 27197744    Free PMC article.
High prevalence of luminal B breast cancer intrinsic subtype in Colombian women.
Silvia Juliana Serrano-Gomez, Maria Carolina Sanabria-Salas, +7 authors, Jovanny Zabaleta.
Carcinogenesis, 2016 May 22; 37(7). PMID: 27207651    Free PMC article.
Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.
Ralph M Wirtz, Harri Sihto, +12 authors, Heikki Joensuu.
Breast Cancer Res Treat, 2016 May 26; 157(3). PMID: 27220750    Free PMC article.
The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.
Nataliya Babyshkina, Sergey Vtorushin, +7 authors, Evgeny Choynzonov.
Clin Exp Med, 2016 May 27; 17(3). PMID: 27225751
Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.
Yawen Guo, Pan Yu, +5 authors, Tao Huang.
PLoS One, 2016 May 27; 11(5). PMID: 27227453    Free PMC article.
Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing α-tubulin acetylation in breast cancer.
X-H Liao, J-G Wang, +11 authors, P Zhou.
Cell Death Dis, 2016 May 27; 7. PMID: 27228351    Free PMC article.
Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
Yunseon Choi, Sung Kwang Park, +4 authors, Yun-Han Lee.
J Korean Med Sci, 2016 Jun 02; 31(6). PMID: 27247497    Free PMC article.
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
Xiaorong Zhong, Zhengwei Dong, +11 authors, Hong Zheng.
PLoS One, 2016 Jun 04; 11(6). PMID: 27257965    Free PMC article.
Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer.
Ling Yao, Yayun Chi, +4 authors, Zhi-Ming Shao.
Oncotarget, 2016 Jun 05; 7(33). PMID: 27259993    Free PMC article.
Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer.
Maria J Fernández-Cabezudo, Issam Faour, +16 authors, Mercedes Rincon.
JCI Insight, 2016 Jun 09; 1(7). PMID: 27275014    Free PMC article.
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
Shusma C Doebar, Esther C van den Broek, +4 authors, Carolien H M van Deurzen.
Breast Cancer Res Treat, 2016 Jun 20; 158(1). PMID: 27318854    Free PMC article.
Patterns of distant metastasis in Chinese women according to breast cancer subtypes.
San-Gang Wu, Jia-Yuan Sun, +7 authors, Zhen-Yu He.
Oncotarget, 2016 Jun 21; 7(30). PMID: 27322074    Free PMC article.
Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer.
Sasagu Kurozumi, Yuri Yamaguchi, +9 authors, Masafumi Kurosumi.
Cancer Med, 2016 Jun 24; 5(8). PMID: 27334118    Free PMC article.
Treatment and survival patterns of Chinese patients diagnosed with breast cancer between 2005 and 2009 in Southwest China: An observational, population-based cohort study.
Zuxiang Peng, Jia Wei, +5 authors, Jing Jing.
Medicine (Baltimore), 2016 Jun 24; 95(25). PMID: 27336872    Free PMC article.
Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
Inna Tishchenko, Heloisa Helena Milioli, Carlos Riveros, Pablo Moscato.
PLoS One, 2016 Jun 25; 11(6). PMID: 27341628    Free PMC article.
The incidence of breast cancer in population of young women from Podkarpackie province in 2002-2011.
Aneta U Radziszewska, Bożenna Karczmarek-Borowska, Monika Grądalska-Lampart, Agata A Filip.
Contemp Oncol (Pozn), 2016 Jul 01; 20(2). PMID: 27358599    Free PMC article.
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.
Mary M Heckler, Tizita Zewde Zeleke, +8 authors, Rebecca B Riggins.
Oncotarget, 2016 Jul 01; 7(30). PMID: 27363015    Free PMC article.
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
Giancarlo Pruneri, Kathryn P Gray, +14 authors, Marco Colleoni.
Breast Cancer Res Treat, 2016 Jul 04; 158(2). PMID: 27372069    Free PMC article.
Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
Eun-Shin Lee, Wonshik Han, +9 authors, Eun Sook Lee.
BMC Cancer, 2016 Jul 09; 16. PMID: 27388210    Free PMC article.
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.
Patrizia Ferroni, Silvia Riondino, +9 authors, Mario Roselli.
Oncologist, 2016 Jul 09; 21(9). PMID: 27388232    Free PMC article.
Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Mark Laible, Kornelia Schlombs, +8 authors, Ugur Sahin.
BMC Cancer, 2016 Jul 09; 16. PMID: 27389414    Free PMC article.
Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
Vera Kloten, Martin Schlensog, +7 authors, Edgar Dahl.
PLoS One, 2016 Jul 12; 11(7). PMID: 27400234    Free PMC article.
Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin.
Ruo-Xi Wang, Sheng Chen, Xi Jin, Zhi-Ming Shao.
Sci Rep, 2016 Jul 19; 6. PMID: 27426056    Free PMC article.
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.
Mario Roselli, Patrizia Ferroni, +9 authors, Fiorella Guadagni.
Am J Cancer Res, 2016 Jul 19; 6(6). PMID: 27429857    Free PMC article.
The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer.
Cetin Ordu, Kandace McGuire, +13 authors, Vahit Ozmen.
Cureus, 2016 Jul 20; 8(6). PMID: 27433412    Free PMC article.
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.
Sasagu Kurozumi, Yuri Yamaguchi, +3 authors, Jun Horiguchi.
J Hum Genet, 2016 Jul 22; 62(1). PMID: 27439682
Review.
Outcome Disparities in African American Compared with European American Women with ER+HER2- Tumors Treated within an Equal-Access Health Care System.
Nicholas S Costantino, Benjamin Freeman, Craig D Shriver, Rachel E Ellsworth.
Ethn Dis, 2016 Jul 22; 26(3). PMID: 27440982    Free PMC article.
Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.
Tom Maishman, Ramsey I Cutress, +4 authors, Diana M Eccles.
Ann Surg, 2016 Jul 28; 266(1). PMID: 27455160    Free PMC article.
Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer.
Eva Lorsy, Aylin Sophie Topuz, +8 authors, Edgar Dahl.
PLoS One, 2016 Jul 29; 11(7). PMID: 27467270    Free PMC article.
Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.
M Miyan, J Schmidt-Mende, +2 authors, J de Boniface.
J Transl Med, 2016 Jul 31; 14(1). PMID: 27473163    Free PMC article.
Correlation between Ultrasound Findings of Tumor Margin and Clinicopathological Findings in Patients with Invasive Ductal Carcinoma of the Breast.
Naoko Sannomiya, Yuiko Hattori, +13 authors, Yasuaki Hirooka.
Yonago Acta Med, 2016 Aug 06; 59(2). PMID: 27493488    Free PMC article.
The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer.
Weisun Huang, Weiwei Nie, +3 authors, Xiaoxiang Guan.
Onco Targets Ther, 2016 Aug 09; 9. PMID: 27499632    Free PMC article.
High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.
Mustapha Abubakar, William J Howat, +40 authors, Montserrat Garcia-Closas.
J Pathol Clin Res, 2016 Aug 09; 2(3). PMID: 27499923    Free PMC article.
DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases.
Jing Xu, Lei Huang, Jun Li.
Oncotarget, 2016 Aug 17; 7(37). PMID: 27528028    Free PMC article.
MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy.
XiaoRong Zhong, GuiQin Xie, +8 authors, Hong Zheng.
Oncotarget, 2016 Aug 18; 7(38). PMID: 27533459    Free PMC article.
Luminal B breast cancer: patterns of recurrence and clinical outcome.
Zhi-Hua Li, Ping-Hua Hu, Jian-Hong Tu, Ni-Si Yu.
Oncotarget, 2016 Aug 20; 7(40). PMID: 27542253    Free PMC article.
QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.
Gøril Knutsvik, Karin Collett, +2 authors, Ingunn M Stefansson.
Mod Pathol, 2016 Aug 27; 29(12). PMID: 27562495
Operation with less adjuvant therapy for elderly breast cancer.
Akimitsu Yamada, Kazutaka Narui, +5 authors, Itaru Endo.
J Surg Res, 2016 Aug 28; 204(2). PMID: 27565077    Free PMC article.
Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
Justinas Besusparis, Benoit Plancoulaine, +6 authors, Arvydas Laurinavicius.
Diagn Pathol, 2016 Sep 01; 11(1). PMID: 27576949    Free PMC article.
Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Yan Fang, Jiayi Wu, +9 authors, Li Zhu.
Oncotarget, 2016 Sep 01; 7(39). PMID: 27577080    Free PMC article.
Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Almir G V Bitencourt, Eduardo N P Lima, +3 authors, Rubens Chojniak.
Eur Radiol, 2016 Sep 03; 27(5). PMID: 27585658
Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features.
Sea-Won Lee, Kyung Hwan Shin, +10 authors, Kyubo Kim.
Oncotarget, 2016 Sep 03; 7(49). PMID: 27588485    Free PMC article.
Molecular subtypes and imaging phenotypes of breast cancer.
Nariya Cho.
Ultrasonography, 2016 Sep 08; 35(4). PMID: 27599892    Free PMC article.
Review.
Risk factors for seroma evacuation in breast cancer patients treated with intraoperative radiotherapy.
Michał Falco, Bartłomiej Masojć, +6 authors, Andrzej Kram.
Rep Pract Oncol Radiother, 2016 Sep 08; 21(3). PMID: 27601955    Free PMC article.
Long-term outcome in young women with breast cancer: a population-based study.
Hanna Fredholm, Kristina Magnusson, +8 authors, Irma Fredriksson.
Breast Cancer Res Treat, 2016 Sep 15; 160(1). PMID: 27624330    Free PMC article.
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Carolin C Hack, Peter A Fasching, +47 authors, Daniela Paepke.
Integr Cancer Ther, 2016 Sep 16; 16(2). PMID: 27627986    Free PMC article.
TP53 drives invasion through expression of its Δ133p53β variant.
Gilles Gadea, Nikola Arsic, +17 authors, Pierre Roux.
Elife, 2016 Oct 18; 5. PMID: 27630122    Free PMC article.
Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.
Ippei Fukada, Kazuhiro Araki, +10 authors, Yoshinori Ito.
PLoS One, 2016 Sep 16; 11(9). PMID: 27631393    Free PMC article.
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.
André Hennigs, Fabian Riedel, +13 authors, Andreas Schneeweiss.
BMC Cancer, 2016 Sep 17; 16(1). PMID: 27634735    Free PMC article.
RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
Peipei Lou, Chunlian Li, +8 authors, Qiang Ding.
Oncotarget, 2016 Sep 17; 8(10). PMID: 27634883    Free PMC article.
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer.
Yong Hwa Eom, Hyung Suk Kim, +2 authors, Byung Joo Chae.
J Breast Cancer, 2016 Oct 11; 19(3). PMID: 27721874    Free PMC article.
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer.
Anna Nordenskjöld, Helena Fohlin, +3 authors, Olle Stål.
Breast Cancer Res Treat, 2016 Oct 11; 160(2). PMID: 27722840    Free PMC article.
Improving systemic breast cancer therapy: time to look beyond the primary tumour?
E Vandendriessche, G Van De Putte, R Van Den Broecke, Etm De Jonge.
Facts Views Vis Obgyn, 2016 Oct 13; 7(4). PMID: 27729970    Free PMC article.
Review.
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
Sophia Frentzas, Eve Simoneau, +28 authors, Andrew R Reynolds.
Nat Med, 2016 Nov 01; 22(11). PMID: 27748747    Free PMC article.
Highly Cited.
Genetic code expansion for multiprotein complex engineering.
Christine Koehler, Paul F Sauter, +24 authors, Edward A Lemke.
Nat Methods, 2016 Nov 01; 13(12). PMID: 27749839
Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.
Meriem Slaoui, Fatima Zahra Mouh, +3 authors, Mariam Amrani.
PLoS One, 2016 Oct 21; 11(10). PMID: 27760178    Free PMC article.
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Amro Masarwah, Päivi Auvinen, +6 authors, Ritva Vanninen.
BMC Cancer, 2016 Nov 04; 16(1). PMID: 27806715    Free PMC article.
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.
Juliane Strietz, Stella S Stepputtis, +14 authors, Jochen Maurer.
Oncotarget, 2016 Nov 10; 7(50). PMID: 27829216    Free PMC article.
The associations between mast cell infiltration, clinical features and molecular types of invasive breast cancer.
Jianfeng Sang, Dandan Yi, +2 authors, Tao Huang.
Oncotarget, 2016 Nov 12; 7(49). PMID: 27835573    Free PMC article.
Diagnostic Performance of Diffusion Tensor Imaging with Readout-segmented Echo-planar Imaging for Invasive Breast Cancer: Correlation of ADC and FA with Pathological Prognostic Markers.
Ken Yamaguchi, Takahiko Nakazono, +4 authors, Hiroyuki Irie.
Magn Reson Med Sci, 2016 Nov 18; 16(3). PMID: 27853053    Free PMC article.
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Victoria L Bridgeman, Peter B Vermeulen, +19 authors, Andrew R Reynolds.
J Pathol, 2016 Nov 20; 241(3). PMID: 27859259    Free PMC article.
Highly Cited.
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.
Gabriele Corda, Gianluca Sala, +22 authors, Arturo Sala.
J Pathol, 2016 Nov 20; 241(3). PMID: 27859262    Free PMC article.
Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research.
Natini Jinawath, Sacarin Bunbanjerdsuk, +4 authors, Varodom Charoensawan.
J Transl Med, 2016 Nov 24; 14(1). PMID: 27876057    Free PMC article.
Review.
Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients.
B Szekely, Zs I Nagy, +13 authors, J Kulka.
Clin Exp Metastasis, 2016 Nov 26; 34(1). PMID: 27885435
FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics.
Stella Petroni, Lucia Caldarola, +4 authors, Giovanni Simone.
Oncol Lett, 2016 Dec 03; 12(5). PMID: 27899970    Free PMC article.
A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse.
Aleix Prat, Ana Lluch, +22 authors, Emilio Alba.
Clin Cancer Res, 2016 Dec 03; 23(12). PMID: 27903675    Free PMC article.
Detection of gene copy number alterations in DCIS and invasive breast cancer by QM-FISH.
Aifeng Pan, Yawei Zhou, +4 authors, Li Li.
Am J Transl Res, 2016 Dec 03; 8(11). PMID: 27904700    Free PMC article.
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Paul Gaß, Peter A Fasching, +47 authors, Christian R Löhberg.
Breast Care (Basel), 2016 Dec 07; 11(5). PMID: 27920623    Free PMC article.
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Natsue Uehiro, Fumiaki Sato, +6 authors, Masakazu Toi.
Breast Cancer Res, 2016 Dec 21; 18(1). PMID: 27993161    Free PMC article.
Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapy.
San-Gang Wu, Jia-Yuan Sun, +2 authors, Zhen-Yu He.
Ther Clin Risk Manag, 2016 Dec 23; 12. PMID: 28008263    Free PMC article.
Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
Liang Huang, Sheng Chen, Wentao T Yang, Zhiming Shao.
Oncotarget, 2017 Jan 06; 8(24). PMID: 28055977    Free PMC article.
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2- breast cancers by the 2015 St. Gallen consensus classification.
Yue Hu, Ran Gu, +9 authors, Weijuan Jia.
BMC Cancer, 2017 Jan 08; 17(1). PMID: 28061893    Free PMC article.
Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.
Jeffrey Landercasper, Barbara Bennie, +4 authors, Jared H Linebarger.
Ann Surg Oncol, 2017 Jan 08; 24(6). PMID: 28062931    Free PMC article.
PET Probe-Guided Surgery in Patients with Breast Cancer: Proposal for a Methodological Approach.
Paolo Orsaria, Agostino Chiaravalloti, +8 authors, Oreste Claudio Buonomo.
In Vivo, 2017 Jan 09; 31(1). PMID: 28064227    Free PMC article.
First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.
Manal Elidrissi Errahhali, Mounia Elidrissi Errahhali, +3 authors, Mohammed Bellaoui.
BMC Womens Health, 2017 Jan 11; 17(1). PMID: 28068979    Free PMC article.
Conditional disease-free survival among patients with breast cancer.
Hyun-June Paik, Se Kyung Lee, +7 authors, Seok Jin Nam.
Medicine (Baltimore), 2017 Jan 11; 96(1). PMID: 28072715    Free PMC article.
Diabetes and Breast Cancer Subtypes.
Heleen K Bronsveld, Vibeke Jensen, +8 authors, Marjanka K Schmidt.
PLoS One, 2017 Jan 12; 12(1). PMID: 28076434    Free PMC article.
MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.
Einas M Yousef, Daniela Furrer, +4 authors, Louis A Gaboury.
Mod Pathol, 2017 Jan 14; 30(5). PMID: 28084344
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Huiyan Ma, Giske Ursin, +13 authors, Leslie Bernstein.
Breast Cancer Res, 2017 Jan 15; 19(1). PMID: 28086982    Free PMC article.
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.
Luca Magnani, Gianmaria Frige, +16 authors, Saverio Minucci.
Nat Genet, 2017 Jan 24; 49(3). PMID: 28112739    Free PMC article.
TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.
Kailin Yin, Yanchen Liu, Ming Chu, Yuedan Wang.
PLoS One, 2017 Jan 24; 12(1). PMID: 28114432    Free PMC article.
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Merete Ellingjord-Dale, Linda Vos, +3 authors, Giske Ursin.
Breast Cancer Res, 2017 Jan 25; 19(1). PMID: 28114999    Free PMC article.
Clinico-Pathologic Subtypes of Breast Cancer Primary Tumors Are Related to Prognosis after Recurrence
Cesar Sánchez, Mauricio Camus, +8 authors, Francisco Acevedo.
Asian Pac J Cancer Prev, 2017 Jan 27; 17(12). PMID: 28122438    Free PMC article.
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Esperanza Martín-Sánchez, Saioa Mendaza, +7 authors, David Guerrero-Setas.
Clin Epigenetics, 2017 Feb 06; 9. PMID: 28149335    Free PMC article.
Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis.
Sandi Shen, Shizhen Zhong, +2 authors, Wenhua Huang.
Onco Targets Ther, 2017 Feb 09; 10. PMID: 28176944    Free PMC article.
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Esperanza Martín-Sánchez, Saioa Mendaza, +11 authors, David Guerrero-Setas.
Oncotarget, 2017 Feb 09; 8(9). PMID: 28178655    Free PMC article.
A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method.
Min Hye Jang, Hyun Jung Kim, +2 authors, So Yeon Park.
PLoS One, 2017 Feb 12; 12(2). PMID: 28187177    Free PMC article.
An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells.
Asako Sasahara, Kana Tominaga, +11 authors, Noriko Gotoh.
Oncotarget, 2017 Feb 17; 8(15). PMID: 28206960    Free PMC article.
Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis.
Weiqiang Qiao, Linlin Pan, +2 authors, Ming Yang.
PLoS One, 2017 Feb 18; 12(2). PMID: 28212434    Free PMC article.
Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Balázs Ács, Veronika Zámbó, +9 authors, Anna-Mária Tőkés.
Diagn Pathol, 2017 Feb 23; 12(1). PMID: 28222768    Free PMC article.
P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
Yunbao Pan, Yufen Yuan, Guoshi Liu, Yongchang Wei.
PLoS One, 2017 Feb 25; 12(2). PMID: 28235003    Free PMC article.
Correlation of Molecular Subtypes of Invasive Ductal Carcinoma of Breast with Glucose Metabolism in FDG PET/CT: Based on the Recommendations of the St. Gallen Consensus Meeting 2013.
Sun Seong Lee, Sang Kyun Bae, +5 authors, Seok Mo Lee.
Nucl Med Mol Imaging, 2017 Mar 03; 51(1). PMID: 28250861    Free PMC article.
Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes.
Ali Kadivar, Behnam Kamalidehghan, +3 authors, Mohamed Ibrahim Noordin.
Drug Des Devel Ther, 2017 Mar 07; 11. PMID: 28260860    Free PMC article.
Systemic Therapy for Early-Stage Breast Cancer: What the Plastic Surgeon Should Know.
Chad M Teven, Daniel B Schmid, +2 authors, Michael A Howard.
Eplasty, 2017 Mar 16; 17. PMID: 28293332    Free PMC article.
Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.
Jianfu Heng, Xinwu Guo, +8 authors, Jun Wang.
PLoS One, 2017 Mar 17; 12(3). PMID: 28301567    Free PMC article.
The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.
Anna Glajcar, Joanna Szpor, +5 authors, Krzysztof Okoń.
Virchows Arch, 2017 Mar 21; 470(5). PMID: 28315938    Free PMC article.
The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.
V Thewes, R Simon, +24 authors, M Tönjes.
Oncogene, 2017 Mar 21; 36(29). PMID: 28319069
Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1-2) in the Context of Breast Conserving Therapy: First Results Following Commencement of the Intergroup-Sentinel-Mamma (INSEMA) Trial.
T Reimer, A Stachs, +5 authors, B Gerber.
Geburtshilfe Frauenheilkd, 2017 Mar 24; 77(2). PMID: 28331237    Free PMC article.
Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer.
Münire Kayahan, Ufuk Oğuz İdiz, +3 authors, Mahmut Müslümanoğlu.
J Breast Health, 2014 Jan 01; 10(4). PMID: 28331672    Free PMC article.
Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.
Vahit Özmen, Ajlan Atasoy, +9 authors, Pınar Saip.
J Breast Health, 2016 Jan 01; 12(3). PMID: 28331745    Free PMC article.
Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer.
Gamze Uğurluer, Sinan Yavuz, +5 authors, Orhan Demircan.
J Breast Health, 2016 Jan 01; 12(3). PMID: 28331746    Free PMC article.
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2- early breast cancer.
Gyungyub Gong, Mi Jeong Kwon, +15 authors, Young Kee Shin.
Sci Rep, 2017 Mar 30; 7. PMID: 28350001    Free PMC article.
Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology.
Sven Kurbel, Branko Dmitrović, +2 authors, Antonije Juretić.
BMC Cancer, 2017 Mar 31; 17(1). PMID: 28356061    Free PMC article.
Expression of Axl and its prognostic significance in human breast cancer.
Gaoyuan Jin, Zhenzhen Wang, +4 authors, Dechun Liu.
Oncol Lett, 2017 Mar 31; 13(2). PMID: 28356938    Free PMC article.
Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer.
Ki-Tae Hwang, Wonshik Han, +6 authors, Dong-Young Noh.
J Breast Cancer, 2017 Apr 07; 20(1). PMID: 28382095    Free PMC article.
Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.
Joanna A Niemiec, Agnieszka Adamczyk, +10 authors, Beata Sas-Korczyńska.
Am J Transl Res, 2017 Apr 08; 9(3). PMID: 28386369    Free PMC article.
Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age.
Runnak A Majid, Hemin A Hassan, +2 authors, Michael D Hughson.
BMC Womens Health, 2017 Apr 09; 17(1). PMID: 28388952    Free PMC article.
Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
Balázs Ács, Lilla Madaras, +5 authors, Attila Marcell Szász.
Pathol Oncol Res, 2017 Apr 13; 24(1). PMID: 28401450
Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients.
Jiayi Wu, Yan Fang, +11 authors, Kunwei Shen.
Oncotarget, 2017 Apr 14; 8(24). PMID: 28404972    Free PMC article.
Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
N Kobayashi, M Hikichi, +4 authors, T Utsumi.
Clin Transl Oncol, 2017 Apr 15; 19(10). PMID: 28409323
eHealth in Modern Patient-Caregiver Communication: High Rate of Acceptance Among Physicians for Additional Support of Breast Cancer Patients During Long-Term Therapy.
Thomas Kirkovits, Timo Schinkoethe, +4 authors, Rachel Wuerstlein.
JMIR Cancer, 2017 Apr 15; 2(2). PMID: 28410173    Free PMC article.
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
Sung Gwe Ahn, Jae-Hoon Lee, +8 authors, Seung Il Kim.
PLoS One, 2017 Apr 19; 12(4). PMID: 28419166    Free PMC article.
Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Gianluca Tedaldi, Michela Tebaldi, +10 authors, Daniele Calistri.
Oncotarget, 2017 Apr 20; 8(29). PMID: 28423363    Free PMC article.
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
Laura Annaratone, Michele Simonetti, +7 authors, Nicola Crosetto.
Oncotarget, 2017 Apr 21; 8(12). PMID: 28423635    Free PMC article.
Personalized medicine in Europe: not yet personal enough?
Antonello Di Paolo, François Sarkozy, Bettina Ryll, Uwe Siebert.
BMC Health Serv Res, 2017 Apr 21; 17(1). PMID: 28424057    Free PMC article.
Review.
Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer.
Jianfu Heng, Fan Zhang, +7 authors, Jun Wang.
Oncotarget, 2017 Apr 21; 8(15). PMID: 28424414    Free PMC article.
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.
Kristi Krüger, Elisabeth Wik, +14 authors, Lars A Akslen.
Sci Rep, 2017 Apr 26; 7(1). PMID: 28439082    Free PMC article.
Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.
Hai-Yuan Yang, Ding Ma, +6 authors, Zhi-Ming Shao.
Sci Rep, 2017 Apr 27; 7(1). PMID: 28442763    Free PMC article.
Current status of the prognostic molecular biomarkers in breast cancer: A systematic review.
Goro Kutomi, Toru Mizuguchi, +4 authors, Koichi Hirata.
Oncol Lett, 2017 Apr 30; 13(3). PMID: 28454281    Free PMC article.
Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy.
Jing Chang, Jihong Liu, +3 authors, Bin Feng.
Oncol Lett, 2017 Apr 30; 13(3). PMID: 28454303    Free PMC article.
Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.
Hideyuki Ohzawa, Atsushi Miki, +9 authors, Yoshikazu Yasuda.
Oncol Lett, 2017 Apr 30; 13(3). PMID: 28454317    Free PMC article.
Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of Lisbon.
António E Pinto, Teresa Pereira, Giovani L Silva, Saudade André.
Oncol Lett, 2017 Apr 30; 13(4). PMID: 28454358    Free PMC article.
Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes.
Lin Chen, Jinfeng Zhang, +4 authors, Dandan Wang.
Oncotarget, 2017 May 06; 8(26). PMID: 28476034    Free PMC article.
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
Abir A Muftah, Mohammed A Aleskandarany, +7 authors, Andrew R Green.
Breast Cancer Res Treat, 2017 May 10; 164(2). PMID: 28478613    Free PMC article.
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Zsuzsanna Varga, Annette Lebeau, +18 authors, Giuseppe Viale.
Breast Cancer Res, 2017 May 12; 19(1). PMID: 28490348    Free PMC article.
Multigene expression profile testing in breast cancer: is there a role for family physicians?
M A O'Brien, J C Carroll, +21 authors, Canadian Team to Improve Community-Based Cancer Care Along the Continuum.
Curr Oncol, 2017 May 12; 24(2). PMID: 28490923    Free PMC article.
Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists.
M A O'Brien, S Dhesy-Thind, +3 authors, E Grunfeld.
Curr Oncol, 2017 May 12; 24(2). PMID: 28490937    Free PMC article.
Cancer subtypes in aetiological research.
Lorenzo Richiardi, Francesco Barone-Adesi, Neil Pearce.
Eur J Epidemiol, 2017 May 13; 32(5). PMID: 28497292
Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.
Antonio Ieni, Valeria Barresi, +7 authors, Giovanni Tuccari.
Oncol Lett, 2017 May 20; 13(5). PMID: 28521427    Free PMC article.
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
Sasagu Kurozumi, Hiroshi Matsumoto, +6 authors, Masafumi Kurosumi.
BMC Cancer, 2017 May 24; 17(1). PMID: 28532429    Free PMC article.
HNF4A expression as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort.
Patrícia Chaves de Freitas Campos Jucá, Stephany Corrêa, +4 authors, Delcio Matos.
Diagn Pathol, 2017 Jun 07; 12(1). PMID: 28583188    Free PMC article.
Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
Yu-Zhen Feng, Qing-Yan Zhang, +4 authors, Rong Shi.
Oncol Rep, 2017 Jun 07; 38(1). PMID: 28586040    Free PMC article.
Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study.
Javier Cuello-López, Ana Fidalgo-Zapata, Elsa Vásquez-Trespalacios.
Int J Breast Cancer, 2017 Jun 14; 2017. PMID: 28607775    Free PMC article.
Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Juan Yao, Qin Jin, +2 authors, Qi-Chao Ni.
Medicine (Baltimore), 2017 Jun 24; 96(25). PMID: 28640095    Free PMC article.
Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.
Guoli Li, Xinwu Guo, +9 authors, Jun Wang.
J Cancer Res Clin Oncol, 2017 Jul 01; 143(10). PMID: 28664449
Prognostic Impact of Progesterone Receptor Status in Chinese Estrogen Receptor Positive Invasive Breast Cancer Patients.
Nan Yao, Zhenchuan Song, +2 authors, Heng Song.
J Breast Cancer, 2017 Jul 12; 20(2). PMID: 28690652    Free PMC article.
Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Xia Liu, Julia Y S Tsang, +5 authors, Gary M Tse.
Oncologist, 2017 Jul 14; 22(11). PMID: 28701569    Free PMC article.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Miguel Martín, José I Chacón, +19 authors, Silvia Antolín.
Oncologist, 2017 Jul 14; 22(11). PMID: 28701571    Free PMC article.
FOXP3 Allelic Variants and Haplotype Structures Are Associated with Aggressive Breast Cancer Subtypes.
Bruna Karina Banin Hirata, Roberta Losi Guembarovski, +3 authors, Maria Angelica Ehara Watanabe.
Dis Markers, 2017 Jul 18; 2017. PMID: 28713192    Free PMC article.
Nomograms for preoperative prediction of axillary nodal status in breast cancer.
L Dihge, P-O Bendahl, L Rydén.
Br J Surg, 2017 Jul 19; 104(11). PMID: 28718896    Free PMC article.
The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.
Seher Karsli-Ceppioglu, Aslihan Dagdemir, +4 authors, Dominique Bernard-Gallon.
Sci Rep, 2017 Jul 28; 7(1). PMID: 28747748    Free PMC article.
E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.
Jiang-Bo Liu, Chen-Yi Feng, +4 authors, Xiao-Shan Feng.
World J Surg Oncol, 2017 Aug 03; 15(1). PMID: 28764784    Free PMC article.
Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
Sayaka Obayashi, Jun Horiguchi, +10 authors, Hiroyuki Kuwano.
Int J Oncol, 2017 Aug 03; 51(3). PMID: 28766688    Free PMC article.
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.
Sung Hoon Sim, Chang-Dae Bae, +16 authors, Jungsil Ro.
PLoS One, 2017 Aug 05; 12(8). PMID: 28771517    Free PMC article.
Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231.
Christian Garbar, Corinne Mascaux, +2 authors, Armand Bensussan.
Sci Rep, 2017 Aug 05; 7(1). PMID: 28775276    Free PMC article.
A comparative study of Ki-67 antigen expression between luminal A and triple-negative subtypes of breast cancer.
Umbelina Soares Borges, Danylo Rafhael Costa-Silva, +6 authors, Pedro Vitor Lopes-Costa.
Med Oncol, 2017 Aug 07; 34(9). PMID: 28780646
Bcl-2 antigen expression in luminal A and triple-negative breast cancer.
Carla Solange Escórcio-Dourado, Luana Mota Martins, +8 authors, Benedito Borges da Silva.
Med Oncol, 2017 Aug 13; 34(9). PMID: 28801774
Prognostic value of routine laboratory variables in prediction of breast cancer recurrence.
Zhu Zhu, Ling Li, +8 authors, Zhimin Fan.
Sci Rep, 2017 Aug 16; 7(1). PMID: 28811593    Free PMC article.
Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis.
Marina Gándara-Cortes, Ángel Vázquez-Boquete, +10 authors, Tomás García-Caballero.
Virchows Arch, 2017 Aug 22; 472(2). PMID: 28825136
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Elsa Curtit, Xavier Pivot, +35 authors, David G Cox.
Breast Cancer Res, 2017 Aug 24; 19(1). PMID: 28830573    Free PMC article.
Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
Silvia J Serrano-Gómez, María Carolina Sanabria-Salas, +7 authors, Jovanny Zabaleta.
PLoS One, 2017 Aug 24; 12(8). PMID: 28832682    Free PMC article.
Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.
Jung-Yoon Heo, Hawoo Yi, +5 authors, Jeong Eon Lee.
Psychiatry Investig, 2017 Aug 29; 14(4). PMID: 28845177    Free PMC article.
Separase is a marker for prognosis and mitotic activity in breast cancer.
Natalia Gurvits, Eliisa Löyttyniemi, +3 authors, Kati Talvinen.
Br J Cancer, 2017 Sep 01; 117(9). PMID: 28859055    Free PMC article.
Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry.
Stefan Stefanovic, Ralph Wirtz, +13 authors, Markus Wallwiener.
Oncotarget, 2017 Sep 09; 8(31). PMID: 28881657    Free PMC article.
The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.
Weibin Lian, Fangmeng Fu, +6 authors, Chuan Wang.
Sci Rep, 2017 Sep 16; 7(1). PMID: 28912475    Free PMC article.
Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.
Ana C Gregório, Manuela Lacerda, +3 authors, João Nuno Moreira.
Pathol Oncol Res, 2017 Sep 16; 24(4). PMID: 28913723
Review.
New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
Oreste Claudio Buonomo, Emanuele Caredda, +6 authors, Paolo Orsaria.
PLoS One, 2017 Sep 19; 12(9). PMID: 28922402    Free PMC article.
Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.
Alexis Moscoso, Álvaro Ruibal, +7 authors, Pablo Aguiar.
Eur J Nucl Med Mol Imaging, 2017 Sep 25; 45(2). PMID: 28936601
A pathways-based prediction model for classifying breast cancer subtypes.
Tong Wu, Yunfeng Wang, +2 authors, Jiawei Tian.
Oncotarget, 2017 Sep 25; 8(35). PMID: 28938599    Free PMC article.
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.
Soichiro Takase, Satoshi Kano, +24 authors, Toshitaka Nagao.
Oncotarget, 2017 Sep 25; 8(35). PMID: 28938615    Free PMC article.
Clinical and pathological portraits of axillary presentation breast cancer and effects of preoperative systemic therapy.
Ling Xu, Fang Li, +4 authors, Ling Xin.
Chin J Cancer Res, 2017 Sep 28; 29(4). PMID: 28947869    Free PMC article.
Three-dimensional segmentation of breast masses from digital breast tomosynthesis images.
Stefanie T L Pöhlmann, Yit Y Lim, +3 authors, Susan M Astley.
J Med Imaging (Bellingham), 2017 Sep 28; 4(3). PMID: 28948195    Free PMC article.
Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers.
Elise Deluche, Laurence Venat-Bouvet, +6 authors, Nicole Tubiana-Mathieu.
BMC Cancer, 2017 Sep 29; 17(1). PMID: 28954632    Free PMC article.
Prognostic immune-related gene models for breast cancer: a pooled analysis.
Jianli Zhao, Ying Wang, +6 authors, Kai Chen.
Onco Targets Ther, 2017 Oct 06; 10. PMID: 28979134    Free PMC article.
Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.
Nancy Martínez-Montiel, Maricruz Anaya-Ruiz, Martín Pérez-Santos, Rebeca D Martínez-Contreras.
Genes (Basel), 2017 Oct 06; 8(10). PMID: 28981467    Free PMC article.
Review.
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.
Alfonso Sánchez-Muñoz, Luis Vicioso, +12 authors, Emilio Alba.
Mod Pathol, 2017 Oct 07; 31(2). PMID: 28984296
Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Weiqiang Qiao, Zhiqiang Jia, +6 authors, Sanqiang Li.
PLoS One, 2017 Oct 11; 12(10). PMID: 29016671    Free PMC article.
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Stephan Bernhardt, Michaela Bayerlová, +15 authors, Eva Johanna Kantelhardt.
Breast Cancer Res, 2017 Oct 13; 19(1). PMID: 29020998    Free PMC article.
Predicting Consumer Effort in Finding and Paying for Health Care: Expert Interviews and Claims Data Analysis.
Sandra Long, Karen A Monsen, +2 authors, Saif Khairat.
JMIR Med Inform, 2017 Oct 14; 5(4). PMID: 29025697    Free PMC article.
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.
Audrey Monneur, Anthony Goncalves, +11 authors, François Bertucci.
Oncotarget, 2017 Oct 17; 8(39). PMID: 29029489    Free PMC article.
Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.
Cristiana Ercolani, Caterina Marchiò, +10 authors, Marcella Mottolese.
J Exp Clin Cancer Res, 2017 Oct 17; 36(1). PMID: 29029640    Free PMC article.
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.
Delphine Hequet, Céline Callens, +20 authors, Roman Rouzier.
PLoS One, 2017 Oct 19; 12(10). PMID: 29045452    Free PMC article.
Breast Cancer in Latinas: A Focus on Intrinsic Subtypes Distribution.
Silvia J Serrano-Gómez, Laura Fejerman, Jovanny Zabaleta.
Cancer Epidemiol Biomarkers Prev, 2017 Oct 22; 27(1). PMID: 29054978    Free PMC article.
Review.
Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.
Yasuo Ohashi, Eiichi Shiba, +5 authors, Tsukasa Fujimoto.
Support Care Cancer, 2017 Oct 25; 26(3). PMID: 29063390    Free PMC article.
Persistent homology index as a robust quantitative measure of immunohistochemical scoring.
Akihiro Takiyama, Takashi Teramoto, +2 authors, Shinya Tanaka.
Sci Rep, 2017 Oct 27; 7(1). PMID: 29070862    Free PMC article.
Androgen Receptor Expression in Thai Breast Cancer Patients.
Suthat Chottanapund, M B M Van Duursen, +3 authors, Martin Van den Berg.
Med Sci (Basel), 2017 Oct 31; 4(3). PMID: 29083379    Free PMC article.
Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer.
Hongchao Zhen, Liuting Yang, +4 authors, Qin Li.
Oncotarget, 2017 Nov 02; 8(43). PMID: 29088770    Free PMC article.
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
F Cardoso, J M S Bartlett, +33 authors, S H Giordano.
Ann Oncol, 2017 Nov 02; 29(2). PMID: 29092024    Free PMC article.
Highly Cited.
Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer.
Volker Möbus, Susanne Hell, Marcus Schmidt.
Geburtshilfe Frauenheilkd, 2017 Nov 03; 77(10). PMID: 29093601    Free PMC article.
Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan.
Hung-Wen Lai, Liang-Chih Liu, +14 authors, Fang-Ming Chen.
PLoS One, 2017 Nov 03; 12(11). PMID: 29095832    Free PMC article.
MicroRNA-10b expression in node-negative breast cancer-correlation with metastasis and angiogenesis.
Xia Liu, Yong Guan, Li Wang, Yun Niu.
Oncol Lett, 2017 Nov 09; 14(5). PMID: 29113216    Free PMC article.
Prognostic role of Gli1 expression in breast cancer: a meta-analysis.
Bilan Wang, Ting Yu, +5 authors, Lingli Zhang.
Oncotarget, 2017 Nov 09; 8(46). PMID: 29113369    Free PMC article.
Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
Sung Gwe Ahn, Soong June Bae, +4 authors, Joon Jeong.
PLoS One, 2017 Nov 09; 12(11). PMID: 29117208    Free PMC article.
Molecular Subtypes and Local-Regional Control of Breast Cancer.
Simona Maria Fragomeni, Andrew Sciallis, Jacqueline S Jeruss.
Surg Oncol Clin N Am, 2017 Nov 15; 27(1). PMID: 29132568    Free PMC article.
Review.
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.
Maria Vittoria Dieci, Valentina Guarneri, +15 authors, PierFranco Conte.
Oncologist, 2017 Nov 15; 23(3). PMID: 29133514    Free PMC article.
Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers.
Seho Park, Eunjin Koh, +3 authors, Kyung-Sup Kim.
Oncotarget, 2017 Nov 16; 8(47). PMID: 29137314    Free PMC article.
LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness.
Jia-Min B Pang, Ramyar Molania, +11 authors, Stephen B Fox.
Oncotarget, 2017 Nov 16; 8(48). PMID: 29137369    Free PMC article.
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.
L Buisseret, S Pommey, +13 authors, J Stagg.
Ann Oncol, 2017 Nov 18; 29(4). PMID: 29145561    Free PMC article.
The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint.
Ling Xin, Yin-Hua Liu, Tracey A Martin, Wen G Jiang.
World J Oncol, 2017 Nov 18; 8(2). PMID: 29147432    Free PMC article.
Review.
Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status.
Huizhe Wu, Hui Wang, +10 authors, Minjie Wei.
Oncotarget, 2017 Nov 22; 8(49). PMID: 29156699    Free PMC article.
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Martin P Nilsson, Therese Törngren, +5 authors, Niklas Loman.
Breast Cancer Res Treat, 2017 Nov 23; 168(1). PMID: 29164420    Free PMC article.
Ultrasonographic features of pure ductal carcinoma in situ of the breast: correlations with pathologic features and biological markers.
Hwajin Cha, Yun-Woo Chang, +4 authors, Jung Kyu Ryu.
Ultrasonography, 2017 Nov 25; 37(4). PMID: 29169230    Free PMC article.
Combined Ki67 and ERCC1 for prognosis in non-keratinizing nasopharyngeal carcinoma underwent chemoradiotherapy.
Ying Lu, Haixin Huang, +4 authors, Rensheng Wang.
Oncotarget, 2017 Nov 29; 8(51). PMID: 29179456    Free PMC article.
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.
Thomas Helland, Nina Henne, +12 authors, Håvard Søiland.
Breast Cancer Res, 2017 Dec 01; 19(1). PMID: 29183390    Free PMC article.
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy.
Sara Ravaioli, Maria Maddalena Tumedei, +5 authors, Sara Bravaccini.
Int J Exp Pathol, 2017 Dec 02; 98(5). PMID: 29193395    Free PMC article.
A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy.
Yu Jin Lim, Sea-Won Lee, +9 authors, In Ah Kim.
Cancer Res Treat, 2017 Dec 09; 50(4). PMID: 29216710    Free PMC article.
A rare mixed breast cancer of intraductal and solid papillary with tubular carcinoma histotypes in a young woman.
Xiaohui Zhang, Jie Shi, +5 authors, Qiang Sun.
J Thorac Dis, 2017 Dec 10; 9(9). PMID: 29221345    Free PMC article.
Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Prihantono Prihantono, Mochammad Hatta, +5 authors, Andi Nilawati Usman.
J Oncol, 2017 Dec 12; 2017. PMID: 29225623    Free PMC article.
A case-control study on risk factors of breast cancer in Han Chinese women.
Li-Yuan Liu, Fei Wang, +33 authors, Zhi-Gang Yu.
Oncotarget, 2017 Dec 13; 8(57). PMID: 29228605    Free PMC article.
Clinical role of breast MRI now and going forward.
D Leithner, G J Wengert, +4 authors, K Pinker.
Clin Radiol, 2017 Dec 13; 73(8). PMID: 29229179    Free PMC article.
Review.
Protocol for the BRECAR study: a prospective cohort follow-up on the impact of breast reconstruction timing on health-related quality of life in women with breast cancer.
Maria Herrera de la Muela, Enrique García López, +2 authors, BRECAR Study Group.
BMJ Open, 2017 Dec 21; 7(12). PMID: 29259059    Free PMC article.
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
R Colomer, I Aranda-López, +7 authors, J Palacios-Calvo.
Clin Transl Oncol, 2017 Dec 24; 20(7). PMID: 29273958    Free PMC article.
Review.
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
Kirsi Holli-Helenius, Annukka Salminen, +4 authors, Riitta Parkkola.
BMC Med Imaging, 2017 Dec 30; 17(1). PMID: 29284425    Free PMC article.
GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer.
Jian Zhang, Ying Wu, +5 authors, Zhonghua Wang.
Oncotarget, 2017 Dec 30; 8(62). PMID: 29285301    Free PMC article.
Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients.
Atif Ali Hashmi, Saher Aijaz, +8 authors, Amir Khan.
World J Surg Oncol, 2018 Jan 03; 16(1). PMID: 29291744    Free PMC article.
Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.
Tahani Louhichi, Hanene Saad, +2 authors, Mounir Trimeche.
BMC Cancer, 2018 Jan 08; 18(1). PMID: 29306324    Free PMC article.
Characteristics of Special Type Breast Tumors in Our Center.
Tonguç Utku Yılmaz, Levent Trabzonlu, +4 authors, Zafer Utkan.
Eur J Breast Health, 2018 Jan 13; 14(1). PMID: 29322114    Free PMC article.
Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer.
Khaldoun Rifaï, Gaëlle Judes, +4 authors, Dominique Bernard-Gallon.
Oncotarget, 2018 Jan 18; 8(67). PMID: 29340027    Free PMC article.
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.
L Rydén, N Loman, +7 authors, Å Borg.
Br J Surg, 2018 Jan 18; 105(2). PMID: 29341157    Free PMC article.
Effects of rat bone marrow-derived mesenchymal stem cells on breast cancer cells with differing hormone receptor status.
Ying Wang, Shan Shao, +6 authors, Xinhan Zhao.
Oncol Lett, 2018 Jan 19; 14(6). PMID: 29344162    Free PMC article.
Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Timco Koopman, Henk J Buikema, +2 authors, Bert van der Vegt.
Breast Cancer Res Treat, 2018 Jan 20; 169(1). PMID: 29349710    Free PMC article.
Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
Huiyan Ma, Giske Ursin, +12 authors, Leslie Bernstein.
Breast Cancer Res, 2018 Jan 24; 20(1). PMID: 29357906    Free PMC article.
Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basis.
Tingting Xu, Lin Zhang, +5 authors, Guangyu Tang.
Oncotarget, 2018 Jan 27; 8(69). PMID: 29371992    Free PMC article.
Molecular Subtypes of Indonesian Breast Carcinomas - Lack of Association with Patient Age and Tumor Size
Yeni Rahmawati, Yunita Setyawati, +2 authors, Dewajani Purnomosari.
Asian Pac J Cancer Prev, 2018 Jan 28; 19(1). PMID: 29373908    Free PMC article.
Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
David Oddó, Dahiana Pulgar, +11 authors, César Sánchez.
Asian Pac J Cancer Prev, 2018 Jan 28; 19(1). PMID: 29373911    Free PMC article.
Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors.
Sahar Zaidi, Showket Hussain, +9 authors, Ravi Mehrotra.
Front Oncol, 2018 Jan 30; 7. PMID: 29376027    Free PMC article.
Review.
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.
Sara Jansson, Kristina Aaltonen, +4 authors, Lisa Rydén.
Breast Cancer Res Treat, 2018 Jan 31; 169(2). PMID: 29380207    Free PMC article.
Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study.
Giuseppe Buono, Anna Crispo, +16 authors, Grazia Arpino.
Oncotarget, 2018 Feb 01; 8(70). PMID: 29383194    Free PMC article.
Frequency of breast cancer subtypes among African American women in the AMBER consortium.
Emma H Allott, Joseph Geradts, +24 authors, Melissa A Troester.
Breast Cancer Res, 2018 Feb 08; 20(1). PMID: 29409530    Free PMC article.
Predictors of lymphovascular invasion identified from pathological factors in Chinese patients with breast cancer.
Sandi Shen, Gaofang Xiao, +3 authors, Haibo Zhou.
Oncotarget, 2018 Feb 09; 9(2). PMID: 29416785    Free PMC article.
Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.
Yoshiaki Shinden, Keishi Sugimachi, +4 authors, Koshi Mimori.
Mol Clin Oncol, 2018 Feb 10; 8(1). PMID: 29423222    Free PMC article.
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Michiko Imamura, Takashi Morimoto, +13 authors, Yasuo Miyoshi.
World J Surg Oncol, 2018 Feb 13; 16(1). PMID: 29433529    Free PMC article.
Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.
Lakmini Mudduwa, Harshini Peiris, +2 authors, Thusharie Liyanage.
Breast Cancer (Auckl), 2018 Feb 13; 11. PMID: 29434471    Free PMC article.
Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
Seung Taek Lim, Ye Won Jeon, +2 authors, Young Jin Suh.
Mol Med Rep, 2018 Feb 14; 17(4). PMID: 29436642    Free PMC article.
Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
Endale Hadgu, Daniel Seifu, +7 authors, Mats G Karlsson.
BMC Womens Health, 2018 Feb 16; 18(1). PMID: 29444670    Free PMC article.
Luminal A Breast Cancer and Molecular Assays: A Review.
Jennifer J Gao, Sandra M Swain.
Oncologist, 2018 Feb 24; 23(5). PMID: 29472313    Free PMC article.
Review.
Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.
Onur Esbah, Berna Oksuzoglu.
Indian J Med Res, 2018 Mar 08; 146(5). PMID: 29512598    Free PMC article.
Review.
Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study.
Lauren B Wright, Minouk J Schoemaker, +2 authors, Anthony J Swerdlow.
Int J Cancer, 2018 Mar 09; 143(4). PMID: 29516507    Free PMC article.
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.
Pernilla Roswall, Matteo Bocci, +24 authors, Kristian Pietras.
Nat Med, 2018 Mar 13; 24(4). PMID: 29529015    Free PMC article.
Highly Cited.
Investigating a multigene prognostic assay based on significant pathways for Luminal A breast cancer through gene expression profile analysis.
Haiyan Gao, Mei Yang, Xiaolan Zhang.
Oncol Lett, 2018 Mar 17; 15(4). PMID: 29545900    Free PMC article.
Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer.
Timothy Kwang Yong Tay, Aye Aye Thike, +12 authors, Puay Hoon Tan.
Oncotarget, 2018 Mar 17; 9(14). PMID: 29545924    Free PMC article.
Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer.
Gaochen Lan, Jie Li, +4 authors, Xi Chen.
Oncol Lett, 2018 Mar 20; 15(4). PMID: 29552143    Free PMC article.
Breast cancer brain metastasis: molecular mechanisms and directions for treatment.
Rute M S M Pedrosa, Dana A Mustafa, Riccardo Soffietti, Johan M Kros.
Neuro Oncol, 2018 Mar 23; 20(11). PMID: 29566179    Free PMC article.
Review.
Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer.
Laura Lozza, Laura Fariselli, +12 authors, Roberto Agresti.
Radiat Oncol, 2018 Mar 24; 13(1). PMID: 29566762    Free PMC article.
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
Giuseppe Bronte, Andrea Rocca, +13 authors, Sara Bravaccini.
BMC Cancer, 2018 Mar 29; 18(1). PMID: 29587674    Free PMC article.
The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
Xin An, Fei Xu, +8 authors, Shusen Wang.
BMC Cancer, 2018 Mar 29; 18(1). PMID: 29587760    Free PMC article.
Analysis of membranous Ki-67 staining in breast cancer and surrounding breast epithelium.
Gábor Cserni.
Virchows Arch, 2018 Mar 30; 473(2). PMID: 29594352
Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India.
Rekha Vijay Kumar, Dipti Panwar, +6 authors, S Krishnamurthy.
South Asian J Cancer, 2018 Mar 31; 7(1). PMID: 29600224    Free PMC article.
Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro.
Lin-Lin Yin, Xin-Mian Wen, +2 authors, Xiu-Wen Wang.
Oncol Lett, 2018 Apr 05; 15(5). PMID: 29616116    Free PMC article.
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
David Groheux, L Biard, +9 authors, P de Cremoux.
Eur J Nucl Med Mol Imaging, 2018 Apr 05; 45(8). PMID: 29616304
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Anne-Laure Renault, Noura Mebirouk, +42 authors, Fabienne Lesueur.
Breast Cancer Res, 2018 Apr 19; 20(1). PMID: 29665859    Free PMC article.
Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Fredrik Strand, Keith Humphreys, +5 authors, Kamila Czene.
Breast Cancer Res, 2018 Apr 20; 20(1). PMID: 29669579    Free PMC article.
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.
David Azria, Muriel Brengues, Sophie Gourgou, Celine Bourgier.
Front Oncol, 2018 Apr 21; 8. PMID: 29675397    Free PMC article.
Review.
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Mariarosaria Incoronato, Anna Maria Grimaldi, +9 authors, Marco Salvatore.
Eur J Nucl Med Mol Imaging, 2018 Apr 27; 45(10). PMID: 29696443
Correlation of Immunohistochemistry and Fluorescence in Situ Hybridization for HER-2 Assessment in Breast Cancer Patients: Single Centre Experience.
Magdalena Bogdanovska-Todorovska, Slavica Kostadinova-Kunovska, +4 authors, Gordana Petrushevska.
Open Access Maced J Med Sci, 2018 May 08; 6(4). PMID: 29731922    Free PMC article.
Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki-67 in Chinese breast cancer patients: A retrospective study of 525 patients.
Yu-Tuan Wu, Xin Li, +6 authors, Ling-Quan Kong.
J Biomed Res, 2018 May 18;. PMID: 29770779    Free PMC article.
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
Julia E C van Steenhoven, Anne Kuijer, +12 authors, Thijs van Dalen.
Genes (Basel), 2018 May 19; 9(5). PMID: 29772837    Free PMC article.
Correlations of aldehyde dehydrogenase-1 (ALDH1) expression with traditional prognostic parameters and different molecular subtypes of breast carcinoma.
Piyabi Sarkar, Keya Basu, +4 authors, Diptendra Kumar Srakar.
Clujul Med, 2018 May 23; 91(2). PMID: 29785156    Free PMC article.
KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy.
Lakmini Mudduwa, Harshini Peiris, +4 authors, Thusharie Liyanage.
BMC Cancer, 2018 May 26; 18(1). PMID: 29793439    Free PMC article.
Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.
Carolin C Hack, Janina Hackl, +6 authors, Anna-Katharin Theuser.
Integr Cancer Ther, 2018 May 31; 17(3). PMID: 29845888    Free PMC article.
Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
Cecilia T Ong, Brittany M Campbell, +8 authors, Oluwadamilola M Fayanju.
Ann Surg Oncol, 2018 Jun 02; 25(8). PMID: 29855830    Free PMC article.
A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence score.
Feilin Qu, Xiaosong Chen, +10 authors, Kunwei Shen.
Chin J Cancer Res, 2018 Jun 05; 30(2). PMID: 29861607    Free PMC article.
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
Giuseppe Bronte, Sara Bravaccini, +12 authors, Andrea Rocca.
Transl Oncol, 2018 Jun 12; 11(4). PMID: 29890379    Free PMC article.
Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature.
Jia-Wei Li, Kai Zhang, +4 authors, Cai Chang.
Sci Rep, 2018 Jun 15; 8(1). PMID: 29899425    Free PMC article.
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial.
Stephen J Luen, Rebecca Asher, +13 authors, Sherene Loi.
JAMA Oncol, 2018 Jun 15; 4(10). PMID: 29902286    Free PMC article.
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
Trygve Lofterød, Elin S Mortensen, +11 authors, Inger Thune.
BMC Cancer, 2018 Jun 16; 18(1). PMID: 29902993    Free PMC article.
Imaging and the completion of the omics paradigm in breast cancer.
D Leithner, J V Horvat, +5 authors, K Pinker.
Radiologe, 2018 Jun 28; 58(Suppl 1). PMID: 29947931    Free PMC article.
Review.
Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial.
Tetsu Hayashida, Hiromitsu Jinno, +12 authors, Yuko Kitagawa.
BMC Cancer, 2018 Jun 30; 18(1). PMID: 29954362    Free PMC article.
Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment.
Yongsik Jung, Soo Jung Lee, +28 authors, Sehwan Han.
J Breast Cancer, 2018 Jul 03; 21(2). PMID: 29963114    Free PMC article.
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.
Nelson Rangel, Nicoletta Fortunati, +12 authors, Isabella Castellano.
BMC Cancer, 2018 Jul 05; 18(1). PMID: 29970021    Free PMC article.
Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).
Meriem Slaoui, Abdou Azaque Zoure, +4 authors, Mariam Amrani.
BMC Cancer, 2018 Jul 07; 18(1). PMID: 29976157    Free PMC article.
Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
Lakmini Kb Mudduwa, Gaya B Wijayaratne, +3 authors, Nimsha Liyanage.
Int J Womens Health, 2018 Jul 10; 10. PMID: 29983596    Free PMC article.
Presentation of the Molecular Subtypes of Breast Cancer Detected By Immunohistochemistry in Surgically Treated Patients.
Borislav Kondov, Zvonko Milenkovikj, +5 authors, Ljube Ivkovski.
Open Access Maced J Med Sci, 2018 Jul 10; 6(6). PMID: 29983785    Free PMC article.
Predictors of internal mammary lymph nodes (IMLN) metastasis and disease-free survival comparison between IMLN-positive and IMLN-negative breast cancer patients: Results from Western China Clinical Cooperation Group (WCCCG) database (CONSORT).
Kang Wang, Xiang Zhang, +12 authors, Hong-Yuan Li.
Medicine (Baltimore), 2018 Jul 12; 97(28). PMID: 29995764    Free PMC article.
TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
Christian Breunig, Nese Erdem, +9 authors, Stefan Wiemann.
Mol Oncol, 2018 Jul 14; 12(9). PMID: 30004628    Free PMC article.
Low‑frequency ultrasound and microbubbles combined with simvastatin promote the apoptosis of MCF‑7 cells by affecting the LATS1/YAP/RHAMM pathway.
Haige Li, Chen Chen, Dehang Wang.
Mol Med Rep, 2018 Jul 18; 18(3). PMID: 30015955    Free PMC article.
Correlation of BMI with breast cancer subtype and tumour size.
K Govind Babu, Abhishek Anand, +12 authors, Rekha V Kumar.
Ecancermedicalscience, 2018 Jul 24; 12. PMID: 30034522    Free PMC article.
Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.
Z E Winters, J Horsnell, +13 authors, A M Brunt.
BJS Open, 2018 Aug 07; 2(4). PMID: 30079385    Free PMC article.
Review.
SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer.
Khaldoun Rifaï, Gaëlle Judes, +4 authors, Dominique Bernard-Gallon.
Oncotarget, 2018 Aug 11; 9(55). PMID: 30093977    Free PMC article.
Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.
Nooshin Hashemi-Sadraei, Gaëlle M Müller-Greven, +15 authors, Candece L Gladson.
J Neurooncol, 2018 Aug 11; 140(2). PMID: 30094720
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers.
Atif Ali Hashmi, Raeesa Mahboob, +7 authors, Muhammad Muzzammil Edhi.
BMC Res Notes, 2018 Aug 15; 11(1). PMID: 30103802    Free PMC article.
Amyloid Precursor Protein Is Associated with Aggressive Behavior in Nonluminal Breast Cancers.
Julia Y S Tsang, Michelle A Lee, +5 authors, Gary M K Tse.
Oncologist, 2018 Aug 16; 23(11). PMID: 30108157    Free PMC article.
Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes.
Çetin Ordu, Kezban Nur Pilancı, +14 authors, Vahit Özmen.
Eur J Breast Health, 2018 Aug 21; 14(3). PMID: 30123884    Free PMC article.
Traditional Chinese Medicine Extract from Huaier Increases the Expression of Duffy Antigen Receptor for Chemokines and Reduces the Expression of Its Ligands.
Ying Chen, Qianjun Chen, +6 authors, Wanjun Xie.
Anal Cell Pathol (Amst), 2018 Aug 25; 2018. PMID: 30140603    Free PMC article.
Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Essam Ayad, Ahmed Soliman, +3 authors, Youhong Dong.
Diagn Pathol, 2018 Aug 30; 13(1). PMID: 30153851    Free PMC article.
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification.
Gali Yanovich, Hadar Agmon, +3 authors, Tamar Geiger.
Cancer Res, 2018 Aug 30; 78(20). PMID: 30154156    Free PMC article.
A Machine Learning Approach for the Association of ki-67 Scoring with Prognostic Factors.
E Dirican, E Kiliç.
J Oncol, 2018 Aug 31; 2018. PMID: 30158977    Free PMC article.
Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype.
Mia M Gaudet, Gretchen L Gierach, +13 authors, Louise A Brinton.
Cancer Res, 2018 Sep 07; 78(20). PMID: 30185547    Free PMC article.
Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
Guoli Li, Xinwu Guo, +11 authors, Jun Wang.
PLoS One, 2018 Sep 14; 13(9). PMID: 30212483    Free PMC article.
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence.
Andrea Rocca, Roberta Maltoni, +2 authors, Daniele Andreis.
Cancer Manag Res, 2018 Sep 15; 10. PMID: 30214302    Free PMC article.
Review.
Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study.
Zhiyang Liu, Zeyad Sahli, +3 authors, Christopher B Umbricht.
Breast Cancer Res Treat, 2018 Sep 19; 172(3). PMID: 30225619    Free PMC article.
Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population.
Mustapha Abubakar, Hyuna Sung, +4 authors, Xiaohong R Yang.
Breast Cancer Res, 2018 Sep 20; 20(1). PMID: 30227867    Free PMC article.
Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
Hiroko Toda, Sasagu Kurozumi, +9 authors, Naohiko Seki.
J Hum Genet, 2018 Sep 20; 63(12). PMID: 30228364
TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
Ling-Yu Ding, Ming Chu, +5 authors, Yue-Dan Wang.
PLoS One, 2018 Sep 21; 13(9). PMID: 30235236    Free PMC article.
Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer.
Ma-Wen Juan, Ji Yu, +3 authors, Liu-Pei Fang.
Oncol Lett, 2018 Sep 27; 16(4). PMID: 30250576    Free PMC article.
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification.
Ming Zhao, Kuang Fu, +6 authors, Jiawei Tian.
Oncol Lett, 2018 Sep 27; 16(4). PMID: 30250578    Free PMC article.
Silencing human epidermal growth factor receptor-3 radiosensitizes human luminal A breast cancer cells.
Guofeng He, Xiaoke Di, +3 authors, Shu Zhang.
Cancer Sci, 2018 Sep 28; 109(12). PMID: 30259607    Free PMC article.
Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study.
Wei Wang, Xiaosong Chen, +12 authors, Kunwei Shen.
J Cancer, 2018 Oct 03; 9(18). PMID: 30271480    Free PMC article.
Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancer.
Fangmeng Fu, Wenhui Guo, +4 authors, Chuan Wang.
J Transl Med, 2018 Oct 05; 16(1). PMID: 30285756    Free PMC article.
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome.
Burcu Çakar, Zeki Sürmeli, +3 authors, Ruchan Uslu.
Eur J Breast Health, 2018 Oct 06; 14(4). PMID: 30288495    Free PMC article.
Using microarray-based subtyping methods for breast cancer in the era of high-throughput RNA sequencing.
Christina Bligaard Pedersen, Finn Cilius Nielsen, Maria Rossing, Lars Rønn Olsen.
Mol Oncol, 2018 Oct 06; 12(12). PMID: 30289602    Free PMC article.
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Siqin Gaowa, Manabu Futamura, +5 authors, Kazuhiro Yoshida.
Cancer Sci, 2018 Oct 06; 109(12). PMID: 30290054    Free PMC article.
Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis.
Yu-Tuan Wu, Zhou Xu, +8 authors, Ling-Quan Kong.
Ther Clin Risk Manag, 2018 Oct 13; 14. PMID: 30310287    Free PMC article.
Review.
Young age is an independent adverse prognostic factor in early stage breast cancer: a population-based study.
Xiao Zhang, Jian Yang, Haoyang Cai, Yifeng Ye.
Cancer Manag Res, 2018 Oct 13; 10. PMID: 30310322    Free PMC article.
SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression.
Sergio Liarte, José Luis Alonso-Romero, Francisco José Nicolás.
Front Endocrinol (Lausanne), 2018 Oct 16; 9. PMID: 30319540    Free PMC article.
Review.
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect.
Qian Lei, Lu Xiong, +10 authors, Luoting Yu.
Cell Death Dis, 2018 Oct 20; 9(11). PMID: 30337519    Free PMC article.
Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
Kerstin Hartmann, Kornelia Schlombs, +4 authors, Hans-Anton Lehr.
Diagn Pathol, 2018 Oct 22; 13(1). PMID: 30342538    Free PMC article.
A New Challenge for Radiologists: Radiomics in Breast Cancer.
Paola Crivelli, Roberta Eufrasia Ledda, +3 authors, Maurizio Conti.
Biomed Res Int, 2018 Nov 08; 2018. PMID: 30402486    Free PMC article.
Review.
Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
Usha Salagame, Emily Banks, +2 authors, Karen Canfell.
PLoS One, 2018 Nov 08; 13(11). PMID: 30403669    Free PMC article.
Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women.
Reina Haque, Xiaoqing Xu, +2 authors, Rowan T Chlebowski.
Ethn Dis, 2018 Nov 09; 28(4). PMID: 30405302    Free PMC article.
Prediction model of lymphovascular invasion based on clinicopathological factors in Chinese patients with invasive breast cancer.
Sandi Shen, Guihua Wu, +4 authors, Haibo Zhou.
Medicine (Baltimore), 2018 Nov 10; 97(43). PMID: 30412123    Free PMC article.
Is Monitoring Mean Platelet Volume Necessary in Breast Cancer Patients?
Halil Taskaynatan, Ahmet Alacacioglu, +5 authors, Mustafa Oktay Tarhan.
Open Med (Wars), 2018 Nov 15; 13. PMID: 30426082    Free PMC article.
Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
Javier Cuello-López, Ana Fidalgo-Zapata, Laura López-Agudelo, Elsa Vásquez-Trespalacios.
PLoS One, 2018 Nov 15; 13(11). PMID: 30427884    Free PMC article.
Using the Health Belief Model to explore why women decide for or against the removal of their ovaries to reduce their risk of developing cancer.
Anne Herrmann, Alix Hall, Anthony Proietto.
BMC Womens Health, 2018 Nov 16; 18(1). PMID: 30428865    Free PMC article.
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.
Carina Forsare, Martin Bak, +8 authors, Mårten Fernö.
BMC Cancer, 2018 Dec 12; 18(1). PMID: 30526533    Free PMC article.
Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics.
Santiago Ramón Y Cajal, Stefan Hümmer, +5 authors, Javier Hernandez-Losa.
Histopathology, 2019 Jan 23; 75(1). PMID: 30667539    Free PMC article.
Review.
Whole genome sequencing of breast cancer.
Maria Rossing, Claus Storgaard Sørensen, Bent Ejlertsen, Finn Cilius Nielsen.
APMIS, 2019 Jan 29; 127(5). PMID: 30689231    Free PMC article.
Review.
Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer: A Retrospective Study.
Jiahui Huang, Xiaosong Chen, +7 authors, Kunwei Shen.
Cancer Res Treat, 2019 Feb 13; 51(4). PMID: 30744321    Free PMC article.
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.
Harindra Jayasekara, Robert J MacInnis, +11 authors, John L Hopper.
Int J Cancer, 2019 Feb 17; 145(12). PMID: 30771221    Free PMC article.
Optoacoustic imaging of the breast: correlation with histopathology and histopathologic biomarkers.
Gisela L G Menezes, Ritse M Mann, +5 authors, Ruud M Pijnappel.
Eur Radiol, 2019 May 28; 29(12). PMID: 31134367    Free PMC article.
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes.
Giuseppe Viale, Amy E Hanlon Newell, +5 authors, Patrick Maisonneuve.
Breast Cancer Res Treat, 2019 Aug 20; 178(2). PMID: 31422497    Free PMC article.
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.
Christine Lundgren, Pär-Ola Bendahl, +15 authors, Maria Ekholm.
Breast Cancer Res Treat, 2019 Aug 23; 178(2). PMID: 31432367    Free PMC article.
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study.
Makoto Kubo, Masaaki Kawai, +16 authors, Hiromitsu Jinno.
Breast Cancer Res Treat, 2019 Aug 28; 178(3). PMID: 31451979    Free PMC article.
Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism.
Kubra Karaosmanoglu Yoneten, Murat Kasap, +3 authors, Nihat Zafer Utkan.
Cancer Genomics Proteomics, 2019 Aug 31; 16(5). PMID: 31467232    Free PMC article.
Factors that affect the false negative rate of sentinel lymph node mapping with methylene blue dye alone in breast cancer.
Huang Li, Zhang Jun, Ge Zhi-Cheng, Qu Xiang.
J Int Med Res, 2019 Sep 12; 47(10). PMID: 31507208    Free PMC article.
Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins.
Nora Jung, Veronique Maguer-Satta, Boris Guyot.
Cancers (Basel), 2019 Sep 25; 11(9). PMID: 31547326    Free PMC article.
Review.
Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer.
H Vihervuori, T A Autere, +5 authors, P Kronqvist.
J Cancer Res Clin Oncol, 2019 Sep 29; 145(12). PMID: 31562550    Free PMC article.
21-Gene recurrence score influences the chemotherapy decision for patients with breast cancer of different luminal subtypes.
Wei Wang, Lin Lin, +11 authors, Kunwei Shen.
Oncol Lett, 2019 Oct 04; 18(4). PMID: 31579428    Free PMC article.
Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)-A concordance comparison cohort analysis.
Wen-Pei Wu, Hwa-Koon Wu, +6 authors, Hung-Wen Lai.
PLoS One, 2019 Oct 11; 14(10). PMID: 31600220    Free PMC article.
Comparison of Clinical Features and Treatment Results of Mix Mucinous Carcinomas and Other Atypical Carcinomas of the Breast.
Mustafa Gök, Uğur Topal, +3 authors, Erdoğan Mütevelli Sözüer.
Eur J Breast Health, 2019 Oct 18; 15(4). PMID: 31620680    Free PMC article.
Association between benign thyroid disease and breast cancer: a single center experience.
Chiara Dobrinja, Serena Scomersi, +8 authors, Marina Bortul.
BMC Endocr Disord, 2019 Oct 19; 19(1). PMID: 31623603    Free PMC article.
Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer.
Chaohui Lisa Zhao, Kamaljeet Singh, +7 authors, Yihong Wang.
BMC Cancer, 2019 Nov 05; 19(1). PMID: 31675929    Free PMC article.
Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis.
Qiang Wu, Guangzhi Ma, +4 authors, Qinghua Zhou.
Front Oncol, 2019 Nov 05; 9. PMID: 31681601    Free PMC article.
Systematic Review.
The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy.
Chenjing Zhu, Otilia Menyhart, Balázs Győrffy, Xia He.
BMC Cancer, 2019 Nov 07; 19(1). PMID: 31690268    Free PMC article.
CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Kaibo Guo, Guan Feng, +5 authors, Shanming Ruan.
Mol Med Rep, 2019 Nov 09; 20(6). PMID: 31702806    Free PMC article.
Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial.
Tone Hoel Lende, Marie Austdal, +7 authors, Jan P A Baak.
BMC Cancer, 2019 Nov 11; 19(1). PMID: 31703648    Free PMC article.
Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer.
Xudong Zhu, Jinqi Xue, +7 authors, Yixiao Zhang.
J Cancer, 2019 Nov 19; 10(23). PMID: 31737103    Free PMC article.
Effects of Postoperative Radiotherapy in Early Breast Cancer Patients Older than 75 Years: A Propensity-Matched Analysis.
Linghui Zhou, Pengtao Yang, +9 authors, Zhijun Dai.
J Cancer, 2019 Nov 28; 10(25). PMID: 31772655    Free PMC article.
PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
S Bonin, D Pracella, +3 authors, G Stanta.
Dis Markers, 2019 Nov 30; 2019. PMID: 31781306    Free PMC article.
The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
Shouping Xu, Hongbo Liu, +6 authors, Da Pang.
Cell Death Dis, 2019 Dec 06; 10(12). PMID: 31801944    Free PMC article.
Luminal B is the Most Common Intrinsic Molecular Subtypes of Invasive Ductal Breast Carcinoma Patients in East Kalimantan, Indonesia.
Swandari Paramita, Eko Nugroho Raharjo, +2 authors, Nur Ahlina Hanifah.
Asian Pac J Cancer Prev, 2019 Aug 28; 20(8). PMID: 31450891    Free PMC article.
Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).
Francesco Amato, Giulia Bicchierai, +7 authors, Jacopo Nori.
Radiol Med, 2019 Nov 28; 124(12). PMID: 31773458
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Andrea Ritter, Marc Hirschfeld, +8 authors, Thalia Erbes.
Int J Oncol, 2019 Dec 04; 56(1). PMID: 31789396    Free PMC article.
Clinical Validation of BCT Scores With Prognostic Factors in Hormone Receptor-positive, HER2-negative Early Breast Cancer.
Jeeyeon Lee, Won Hwa Kim, +9 authors, Ho Yong Park.
In Vivo, 2019 Oct 31; 33(6). PMID: 31662548    Free PMC article.
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
Annika Jögi, Anna Ehinger, Linda Hartman, Sara Alkner.
PLoS One, 2019 Dec 11; 14(12). PMID: 31821370    Free PMC article.
The BRASS (BReast Angiosarcoma Surveillance Study): Protocol for a retrospective multicentre cohort study to evaluate the management and outcomes of angiosarcoma of the breast and chest wall.
Jenny Banks, Charlotte Ives, +2 authors, BRASS Steering Group.
Int J Surg Protoc, 2017 May 22; 5. PMID: 31851741    Free PMC article.
Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management.
David André Barrière, Élora Midavaine, +8 authors, Philippe Sarret.
Sci Rep, 2019 Dec 29; 9(1). PMID: 31882872    Free PMC article.
The molecular genetic make-up of male breast cancer.
Cathy B Moelans, Joep de Ligt, +22 authors, Paul J van Diest.
Endocr Relat Cancer, 2019 Jul 25; 26(10). PMID: 31340200    Free PMC article.
T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy.
Xueying Wang, Yingying Xu, +6 authors, Liang Zong.
Oncol Lett, 2020 Jan 04; 19(1). PMID: 31897189    Free PMC article.
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study.
Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, +14 authors, Michele Caruso.
Ther Adv Med Oncol, 2020 Jan 07; 11. PMID: 31903098    Free PMC article.
N-glycosylated SGK196 suppresses the metastasis of basal-like breast cancer cells.
Ci Xu, Meichao Zhang, +3 authors, Dong Li.
Oncogenesis, 2020 Jan 09; 9(1). PMID: 31913260    Free PMC article.
Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.
Eugeni Lopez-Bonet, Maria Buxó, +24 authors, Javier A Menendez.
J Clin Med, 2019 Dec 15; 8(12). PMID: 31835708    Free PMC article.
Predictive factors and prognostic value of pathologic complete response of ipsilateral supraclavicular lymph nodes in breast cancer after neoadjuvant chemotherapy.
Jiujun Zhu, Dechuang Jiao, +8 authors, Zhenzhen Liu.
Ann Transl Med, 2020 Jan 14; 7(22). PMID: 31930067    Free PMC article.
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer.
Xiuzhi Zhu, Li Chen, +8 authors, Zhonghua Wang.
Sci Rep, 2020 Jan 16; 10(1). PMID: 31937819    Free PMC article.
Renalase overexpression in ER-positive breast cancer.
Xuewen Yu, Pengxun Han, +2 authors, Mumin Shao.
Int J Clin Exp Pathol, 2018 Mar 01; 11(3). PMID: 31938225    Free PMC article.
Expression of cleaved caspase-3 predicts good chemotherapy response but poor survival for patients with advanced primary triple-negative breast cancer.
Xiaodan Liu, Shenyi Jiang, Xin Tian, Youhong Jiang.
Int J Clin Exp Pathol, 2018 Sep 01; 11(9). PMID: 31949833    Free PMC article.
The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer.
Xinfeng Zhang, Dandan Wang, +6 authors, Feng Jin.
Quant Imaging Med Surg, 2020 Jan 21; 10(1). PMID: 31956542    Free PMC article.
Pathological Response to Neoadjuvant Chemotherapy and the Molecular Classification of Locally Advanced Breast Cancer in a Latin American Cohort.
Sandra Esperanza Díaz-Casas, Jorge Alberto Castilla-Tarra, +10 authors, Juan Carlos Vergel-Martinez.
Oncologist, 2019 Jul 28; 24(12). PMID: 31346133    Free PMC article.
Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer.
Young-Joon Kang, Han-Byoel Lee, +7 authors, Wonshik Han.
J Oncol, 2020 Jan 25; 2019. PMID: 31975992    Free PMC article.
Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis.
Y Zhao, X Wang, +2 authors, D Zhang.
Clin Transl Oncol, 2019 Apr 22; 22(1). PMID: 31006089
Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival.
José Luis Granados-Soler, Kirsten Bornemann-Kolatzki, +7 authors, Ingo Nolte.
Sci Rep, 2020 Jan 24; 10(1). PMID: 31969654    Free PMC article.
Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study.
Megan A Healey, Kelly A Hirko, +6 authors, Aditi Hazra.
Breast Cancer Res Treat, 2017 Aug 10; 166(2). PMID: 28791482    Free PMC article.
Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer.
Ye Sul Jeong, Jun Kang, +3 authors, Ahwon Lee.
J Pathol Transl Med, 2019 Nov 14; 54(1). PMID: 31718121    Free PMC article.
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling.
Elena Vissio, Jasna Metovic, +7 authors, Isabella Castellano.
Br J Cancer, 2019 Nov 30; 122(3). PMID: 31780778    Free PMC article.
UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.
Xi-Sha Chen, Kuan-Song Wang, +14 authors, Yan Cheng.
Theranostics, 2020 Feb 12; 10(4). PMID: 32042339    Free PMC article.
Prognostic value of skeletal muscle index and monocyte-to-lymphocyte ratio for lymph node-positive breast cancer patients after mastectomy.
Jia-Peng Deng, Xin Hua, +3 authors, Zhen-Yu He.
Ann Transl Med, 2020 Feb 12; 7(23). PMID: 32042791    Free PMC article.
Photoacoustic imaging of breast cancer: a mini review of system design and image features.
Nikhila Nyayapathi, Jun Xia.
J Biomed Opt, 2019 Nov 05; 24(12). PMID: 31677256    Free PMC article.
Review.
Triple-negative mammary carcinoma in two male dogs.
Marília C A Machado, Natalia M Ocarino, +5 authors, Alessandra Estrela-Lima.
J Vet Diagn Invest, 2020 Jan 12; 32(1). PMID: 31924140    Free PMC article.
Agreement between dynamic contrast-enhanced magnetic resonance imaging and pathologic tumour size of breast cancer and analysis of the correlation with BI-RADS descriptors.
Aysegul Akdogan Gemici, Ercan Inci.
Pol J Radiol, 2020 Feb 23; 84. PMID: 32082460    Free PMC article.
Gene expression association study in feline mammary carcinomas.
Daniela Ferreira, Bárbara Martins, +4 authors, Raquel Chaves.
PLoS One, 2019 Aug 29; 14(8). PMID: 31461477    Free PMC article.
Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation.
Maryam Kadivar, Fatemeh Aram.
Iran J Pathol, 2020 Feb 26; 15(1). PMID: 32095144    Free PMC article.
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.
Alison Y Zhang, Karen Chiam, +17 authors, James G Kench.
Int J Cancer, 2018 Oct 06; 144(5). PMID: 30288742    Free PMC article.
Prognostic Utility of Cyclin D1 in Invasive Breast Carcinoma.
Tamanna Parvin, Chhanda Das, +2 authors, Madhumita Mukhopadhyay.
Indian J Surg Oncol, 2019 Apr 06; 10(1). PMID: 30948894    Free PMC article.
miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Danielle Pessôa-Pereira, Adriane Feijó Evangelista, +10 authors, Márcia Maria Chiquitelli Marques.
BMC Cancer, 2020 Feb 24; 20(1). PMID: 32087690    Free PMC article.
Indications for prognostic gene expression profiling in early breast cancer.
Erin F Cobain, Daniel F Hayes.
Curr Treat Options Oncol, 2015 May 02; 16(5). PMID: 25929335
Review.
PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.
Praveen-Kumar Raj-Kumar, Jianfang Liu, +4 authors, Hai Hu.
Sci Rep, 2019 May 30; 9(1). PMID: 31138829    Free PMC article.
21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes.
Yiwei Tong, Jiayi Wu, +6 authors, Kunwei Shen.
Sci Rep, 2019 Sep 13; 9(1). PMID: 31511599    Free PMC article.
Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort.
Zsuzsanna Varga, Qiyu Li, +7 authors, Thomas Ruhstaller.
Sci Rep, 2019 Sep 21; 9(1). PMID: 31537812    Free PMC article.
Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study.
Jenni S Liikanen, Marjut H Leidenius, +2 authors, Tuomo J Meretoja.
Br J Cancer, 2018 Apr 25; 118(11). PMID: 29686324    Free PMC article.
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Kathleen Van Asten, Laurence Slembrouck, +16 authors, Patrick Neven.
Oncologist, 2018 Sep 02; 24(2). PMID: 30171067    Free PMC article.
Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV.
Sung Gwe Ahn, Chang Ik Yoon, +7 authors, Joon Jeong.
Endocr Relat Cancer, 2018 Nov 09; 26(2). PMID: 30407916    Free PMC article.
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
Angelos Koutras, Georgios Lazaridis, +19 authors, George Fountzilas.
PLoS One, 2018 Dec 07; 13(12). PMID: 30521571    Free PMC article.
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
Clément Morgat, Romain Schollhammer, +6 authors, Elif Hindié.
PLoS One, 2019 Jan 16; 14(1). PMID: 30645633    Free PMC article.
Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer.
Yidong Zhou, Yaping Xu, +11 authors, Qiang Sun.
Mol Oncol, 2019 Jan 24; 13(5). PMID: 30672098    Free PMC article.
Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
Laura L Michel, Laura Sommer, +11 authors, Frederik Marmé.
PLoS One, 2019 Feb 01; 14(1). PMID: 30703111    Free PMC article.
Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study.
Sumadi Lukman Anwar, Clarista Adelia Raharjo, +8 authors, Wahyu Wulaningsih.
BMC Womens Health, 2019 Feb 08; 19(1). PMID: 30728000    Free PMC article.
Kinetic Features of Invasive Breast Cancers on Computer-Aided Diagnosis Using 3T MRI Data: Correlation with Clinical and Pathologic Prognostic Factors.
Sung Eun Song, Kyu Ran Cho, +3 authors, Deuk Jae Sung.
Korean J Radiol, 2019 Feb 26; 20(3). PMID: 30799572    Free PMC article.
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study.
Virginia Lope, Miguel Martín, +20 authors, Marina Pollán.
Sci Rep, 2019 Mar 09; 9(1). PMID: 30846706    Free PMC article.
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.
Mustapha Abubakar, Jonine Figueroa, +8 authors, Paul D Pharoah.
Mod Pathol, 2019 Apr 13; 32(9). PMID: 30976105    Free PMC article.
Evaluation of MRI accuracy after primary systemic therapy in breast cancer patients considering tumor biology: optimizing the surgical planning.
Alberto Bouzón, Ángela Iglesias, +3 authors, Joaquín Mosquera.
Radiol Oncol, 2019 May 20; 53(2). PMID: 31104001    Free PMC article.
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed.
Claudio Ceccarelli, Antonio De Leo, +5 authors, Donatella Santini.
PLoS One, 2019 Jun 04; 14(6). PMID: 31158261    Free PMC article.
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
Fabiola Giudici, Elisabetta Petracci, +4 authors, Bruna Scaggiante.
PLoS One, 2019 Jun 21; 14(6). PMID: 31220107    Free PMC article.
Assessment of ERBB2 and TOP2α gene status and expression profile in feline mammary tumors: findings and guidelines.
Daniela Ferreira, Maria Soares, +3 authors, Raquel Chaves.
Aging (Albany NY), 2019 Jul 14; 11(13). PMID: 31301170    Free PMC article.
MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis.
Marianne Samir Makboul Issac, Einas Yousef, Muhammad Ramzan Tahir, Louis A Gaboury.
Neoplasia, 2019 Sep 03; 21(10). PMID: 31476594    Free PMC article.
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Barbara Adamo, Meritxell Bellet, +16 authors, Aleix Prat.
Breast Cancer Res, 2019 Sep 20; 21(1). PMID: 31533777    Free PMC article.
Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective.
Anurag Mehta, Dushyant Kumar, +5 authors, Ajit Panaych.
Indian J Med Res, 2019 Nov 14; 150(3). PMID: 31719296    Free PMC article.
Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer.
Xiao Li, Juliane Strietz, +2 authors, Jochen Maurer.
Int J Mol Sci, 2020 Jan 16; 21(2). PMID: 31936348    Free PMC article.
Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer.
Filiz Çelebi, Filiz Agacayak, +11 authors, Vahit Özmen.
Eur Radiol, 2019 Dec 12; 30(4). PMID: 31822972
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer.
Sören Schnellhardt, Ramona Erber, +8 authors, Luitpold Distel.
Cancers (Basel), 2020 Feb 23; 12(2). PMID: 32075091    Free PMC article.
Expression and Circulating Levels of Perlecan in Breast Cancer - Implications for Oestrogen Dependent Stromal Remodeling.
Malin Jansson, Ola Billing, +4 authors, Malin Sund.
J Mammary Gland Biol Neoplasia, 2020 Mar 04; 25(1). PMID: 32124140
Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Xiao-Xiao Li, Li-Juan Wang, +4 authors, Wen-Hai Xie.
Biomed Res Int, 2020 Mar 20; 2020. PMID: 32190687    Free PMC article.
Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
Yiran Si, Peng Yuan, +8 authors, Binghe Xu.
Ann Surg Oncol, 2020 Jan 24; 27(4). PMID: 31970572    Free PMC article.
Follow-up strategies for women treated for early breast cancer.
Ivan Moschetti, Michela Cinquini, +2 authors, Alessandro Liberati.
Cochrane Database Syst Rev, 2016 May 28; (5). PMID: 27230946    Free PMC article.
Systematic Review.
The subgross morphology of breast carcinomas: a single-institution series of 2033 consecutive cases documented in large-format histology slides.
Tibor Tot, Maria Gere, +2 authors, Ulrika Pellas.
Virchows Arch, 2019 Aug 15; 476(3). PMID: 31410558
Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
Shiteng Suo, Dandan Zhang, +4 authors, Jianrong Xu.
Eur Radiol, 2018 Aug 18; 29(3). PMID: 30116958
Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme.
Sameer Bhargava, Lars Andreas Akslen, Ida Rashida Khan Bukholm, Solveig Hofvind.
Eur Radiol, 2019 Feb 15; 29(9). PMID: 30762109
DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1.
Li Tang, Yuli Chen, +5 authors, Feng Yan.
Front Oncol, 2020 Apr 01; 10. PMID: 32226772    Free PMC article.
Outcomes and prognostic factors for women with breast cancer in Malawi.
Victoria M Youngblood, Ruth Nyirenda, +19 authors, Tamiwe Tomoka.
Cancer Causes Control, 2020 Mar 04; 31(4). PMID: 32124187    Free PMC article.
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
Jiangfeng Wang, Jurui Luo, +9 authors, Xiaomao Guo.
Cancer Med, 2020 Feb 13; 9(7). PMID: 32048817    Free PMC article.
Drug repurposing for breast cancer therapy: Old weapon for new battle.
Sadhna Aggarwal, Sumit Singh Verma, Sumit Aggarwal, Subash Chandra Gupta.
Semin Cancer Biol, 2019 Sep 25; 68. PMID: 31550502    Free PMC article.
Review.
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience.
S Pérez Ramírez, M Del Monte-Millán, +21 authors, M Martín.
Clin Transl Oncol, 2019 Jul 14; 22(5). PMID: 31300934
Neoadjuvant endocrine therapy in breast cancer patients.
Raquel Lobo-Cardoso, André Torres Magalhães, José Luís Fougo.
Porto Biomed J, 2017 Sep 01; 2(5). PMID: 32258615    Free PMC article.
Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital.
Khawaja F Zahid, Shiyam Kumar, +4 authors, Mansour Al-Moundhri.
Oman Med J, 2019 Sep 27; 34(5). PMID: 31555417    Free PMC article.
HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer.
Jing Zhang, Shuo Zhang, +4 authors, Weidong Ren.
Cancer Manag Res, 2020 Apr 11; 12. PMID: 32273760    Free PMC article.
Comprehensive analyses with radiological and biological markers of breast cancer on contrast-enhanced chest CT: a single center experience using dual-layer spectral detector CT.
Jin Il Moon, Bo Hwa Choi, +6 authors, Hyo Jung An.
Eur Radiol, 2020 Feb 07; 30(5). PMID: 32025829
Individual response of humans to ionising radiation: governing factors and importance for radiological protection.
K E Applegate, W Rühm, +17 authors, S Bouffler.
Radiat Environ Biophys, 2020 Mar 09; 59(2). PMID: 32146555
Review.
Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
Yuqin Ding, Kaijing Ding, +9 authors, Xiaowen Ding.
PLoS One, 2020 Apr 17; 15(4). PMID: 32298374    Free PMC article.
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer.
Matthew P Humphries, Sean Hynes, +13 authors, Niamh E Buckley.
J Oncol, 2019 Jan 18; 2018. PMID: 30651729    Free PMC article.
Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China.
Jian Ming Wang, Jun Wang, +2 authors, Fei Yang Wang.
Biomed Res Int, 2020 Apr 28; 2020. PMID: 32337260    Free PMC article.
Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients.
Lifen Cai, Yiwei Tong, +3 authors, Xiaosong Chen.
Sci Rep, 2020 Apr 29; 10(1). PMID: 32341397    Free PMC article.
Tumor-stromal ratio (TSR) of invasive breast cancer: correlation with multi-parametric breast MRI findings.
Ken Yamaguchi, Yukiko Hara, +6 authors, Hiroyuki Irie.
Br J Radiol, 2019 Mar 06; 92(1097). PMID: 30835501    Free PMC article.
Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic.
Covadonga Martí, José I Sánchez-Méndez.
Ecancermedicalscience, 2020 May 06; 14. PMID: 32368252    Free PMC article.
Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study.
Xin Hua, Zhi-Qing Long, +5 authors, Huan-Xin Lin.
Front Oncol, 2020 May 07; 10. PMID: 32373539    Free PMC article.
A genetic variant in microRNA-146a is associated with sporadic breast cancer in a Southern Brazilian Population.
Heloisa Magagnin Brincas, Danillo G Augusto, +8 authors, Enilze Maria de Souza Fonseca Ribeiro.
Genet Mol Biol, 2020 Mar 07; 42(4). PMID: 32142098    Free PMC article.
Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional study.
Endale Hadgu, Daniel Seifu, +6 authors, Mats G Karlsson.
PLoS One, 2020 May 07; 15(5). PMID: 32374753    Free PMC article.
Effect of Ki-67 Expression Levels and Histological Grade on Breast Cancer Early Relapse in Patients with Different Immunohistochemical-based Subtypes.
Qin Liang, Ding Ma, Run-Fang Gao, Ke-Da Yu.
Sci Rep, 2020 May 08; 10(1). PMID: 32376868    Free PMC article.
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer.
María Florencia Mercogliano, Sofía Bruni, Patricia V Elizalde, Roxana Schillaci.
Front Oncol, 2020 May 12; 10. PMID: 32391269    Free PMC article.
Review.
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.
Yaewon Yang, Ahrum Min, +11 authors, Seock-Ah Im.
J Breast Cancer, 2020 May 13; 23(2). PMID: 32395377    Free PMC article.
Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis.
Jia-Wei Li, Na Li, +4 authors, Zhi-Ming Shao.
Ann Transl Med, 2020 May 13; 8(7). PMID: 32395479    Free PMC article.
Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study.
Inés Gómez-Acebo, Trinidad Dierssen-Sotos, +22 authors, Javier Llorca.
Breast Cancer Res Treat, 2020 May 02; 181(3). PMID: 32356254    Free PMC article.
Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing.
Hongyu Xiang, Ling Xin, +7 authors, Ling Xu.
Chin J Cancer Res, 2020 May 16; 32(2). PMID: 32410794    Free PMC article.
AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors.
Nelson Rangel, Milena Rondon-Lagos, +4 authors, Isabella Castellano.
Cells, 2020 Apr 30; 9(4). PMID: 32344660    Free PMC article.
Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions.
Xiping Zhang, Hongjian Yang, Ruiping Zhang.
Biosci Rep, 2019 Aug 08; 39(9). PMID: 31387972    Free PMC article.
Review.
Relationship between Ribosomal Protein S6-pS240 Expression and other Prognostic Factors in Non-Special Type Invasive Breast Cancer.
Frederik Cuperjani, Lumturije Gashi, +2 authors, Fitim Selimi.
Breast Care (Basel), 2019 Jul 19; 14(3). PMID: 31316316    Free PMC article.
Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?
Jing Yu, Jiayi Wu, +6 authors, Kunwei Shen.
Front Oncol, 2020 Jun 02; 10. PMID: 32477946    Free PMC article.
A population-based analysis of breast cancer incidence and survival by subtype in Ontario women.
S J Seung, A N Traore, +3 authors, K J Jerzak.
Curr Oncol, 2020 Jun 04; 27(2). PMID: 32489268    Free PMC article.
Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer.
Hee Jeong Kim, Woo Chul Noh, +7 authors, Sei Hyun Ahn.
Breast Cancer Res, 2020 May 29; 22(1). PMID: 32460816    Free PMC article.
Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.
Sumadi Lukman Anwar, Widya Surya Avanti, +5 authors, Wahyu Wulaningsih.
World J Surg Oncol, 2020 Jun 01; 18(1). PMID: 32473643    Free PMC article.
Triple-negative breast cancer molecular subtyping and treatment progress.
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-Cang Yu.
Breast Cancer Res, 2020 Jun 11; 22(1). PMID: 32517735    Free PMC article.
Review.
DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.
Vladimir O Sigin, Alexey I Kalinkin, +14 authors, Alexander S Tanas.
Sci Rep, 2020 Jun 10; 10(1). PMID: 32514046    Free PMC article.
Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape.
Seokhyun Yoon, Hye Sung Won, +3 authors, Yoon Ho Ko.
Cancers (Basel), 2020 May 10; 12(5). PMID: 32380759    Free PMC article.
Radiomics in Breast Imaging from Techniques to Clinical Applications: A Review.
Seung Hak Lee, Hyunjin Park, Eun Sook Ko.
Korean J Radiol, 2020 Jun 12; 21(7). PMID: 32524780    Free PMC article.
Review.
A prognostic model based on cell-cycle control predicts outcome of breast cancer patients.
Heli Repo, Eliisa Löyttyniemi, +4 authors, Pauliina Kronqvist.
BMC Cancer, 2020 Jun 18; 20(1). PMID: 32546141    Free PMC article.
Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer.
Tímea Tőkés, Anna-Mária Tőkés, +6 authors, Magdolna Dank.
Pathol Oncol Res, 2019 Aug 26; 26(3). PMID: 31446607    Free PMC article.
Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009.
Anne Marie Bak Jylling, Vibeke Jensen, +3 authors, Marianne Djernes Lautrup.
Breast Cancer, 2020 Feb 29; 27(4). PMID: 32108307    Free PMC article.
Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Chitra Joseph, Mansour Alsaleem, +7 authors, Emad A Rakha.
Breast Cancer Res Treat, 2020 May 24; 182(2). PMID: 32445177    Free PMC article.
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Giuseppe Buono, Anna Crispo, +19 authors, Grazia Arpino.
Breast Cancer Res Treat, 2020 Jun 06; 182(2). PMID: 32500397    Free PMC article.
Distribution of the 21-Gene Breast Recurrence Score in Patients with Primary Breast Cancer in Germany.
Vincent P Walter, Florin-Andrei Taran, +6 authors, Andreas Daniel Hartkopf.
Geburtshilfe Frauenheilkd, 2020 Jun 23; 80(6). PMID: 32565552    Free PMC article.
Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.
Qian Pu, Yan-Rong Lv, +2 authors, Hai-Dong Gao.
BMC Cancer, 2020 Jun 24; 20(1). PMID: 32571254    Free PMC article.
Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer.
Yu Song, Bin Zhao, +4 authors, Qiang Sun.
BMC Cancer, 2020 Jun 24; 20(1). PMID: 32571264    Free PMC article.
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
Hidemi Okuma, Mazen Sudah, +7 authors, Ritva Vanninen.
PLoS One, 2020 Jun 26; 15(6). PMID: 32584887    Free PMC article.
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.
I Alvarez-Lopez, S Bezares, +6 authors, A Santaballa Bertrán.
Clin Transl Oncol, 2020 Feb 14; 22(8). PMID: 32052382    Free PMC article.
Review.
Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.
Dovile Zilenaite, Allan Rasmusson, +5 authors, Arvydas Laurinavicius.
Front Oncol, 2020 Jul 03; 10. PMID: 32612954    Free PMC article.
Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
Mitsuru Tanaka, Chung Hsuan, +13 authors, Toshiro Matsui.
PLoS One, 2020 Jul 01; 15(6). PMID: 32598404    Free PMC article.
A sequential methodology for the rapid identification and characterization of breast cancer-associated functional SNPs.
Yihan Zhao, Di Wu, +9 authors, Gang Li.
Nat Commun, 2020 Jul 06; 11(1). PMID: 32620845    Free PMC article.
Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.
Hongna Tan, Yaping Wu, +5 authors, Meiyun Wang.
Br J Radiol, 2020 May 14; 93(1111). PMID: 32401540    Free PMC article.
Identification of a Profile of Neutrophil-Derived Granule Proteins in the Surface of Gold Nanoparticles after Their Interaction with Human Breast Cancer Sera.
María Del Pilar Chantada-Vázquez, María García-Vence, +2 authors, Cristina Núñez.
Nanomaterials (Basel), 2020 Jun 27; 10(6). PMID: 32586001    Free PMC article.
Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay.
Caterina F Donini, Myriam El Helou, +12 authors, Pascale A Cohen.
Front Oncol, 2020 Jul 17; 10. PMID: 32670863    Free PMC article.
Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDER.
Z Sun, A Prat, +2 authors, C M Perou.
Ann Oncol, 2014 Oct 31; 26(1). PMID: 25355719    Free PMC article.
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Claire Bonneau, Antoine Eliès, +9 authors, Fatima Mechta-Grigoriou.
Breast Cancer Res, 2020 Jul 16; 22(1). PMID: 32665033    Free PMC article.
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients.
Zhonghua Tao, Ting Li, +12 authors, Xichun Hu.
Front Oncol, 2020 Jul 23; 10. PMID: 32695676    Free PMC article.
Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women-a literature review and proposed guidelines.
Lauren I Madigan, Phuong Dinh, J Dinny Graham.
Breast Cancer Res, 2020 Jul 22; 22(1). PMID: 32690069    Free PMC article.
Review.
Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
Stephanie Robertson, Balazs Acs, Michael Lippert, Johan Hartman.
Breast Cancer Res Treat, 2020 Jun 24; 183(1). PMID: 32572716    Free PMC article.
Correlation between salivary and serum CA15-3 concentrations in patients with breast cancer.
Daniele Xavier Assad, Elisa Cançado Porto Mascarenhas, +6 authors, Eliete Neves Silva Guerra.
Mol Clin Oncol, 2020 Jul 28; 13(2). PMID: 32714539    Free PMC article.
Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer.
Haoyu Wang, Weiwei Zhan, +3 authors, Kunwei Shen.
Breast, 2019 Nov 05; 49. PMID: 31677531    Free PMC article.
Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results.
Aurelia Noske, Sophie-Isabelle Anders, +6 authors, Evelyn Klein.
Breast, 2019 Dec 02; 49. PMID: 31786414    Free PMC article.
An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
Yi-Xing Wang, Yuan-Yuan Wang, +9 authors, Ju-Lun Yang.
Breast, 2020 Jan 09; 49. PMID: 31911370    Free PMC article.
Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution's Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer.
Angela Fischer Maranta, Simon Broder, +4 authors, Thomas Ruhstaller.
Breast, 2020 Apr 18; 51. PMID: 32302928    Free PMC article.
Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
Garazi Serna, Sara Simonetti, +10 authors, Paolo Nuciforo.
Breast, 2020 Jul 25; 53. PMID: 32707454    Free PMC article.
Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21-gene recurrence score of 26-30.
Jing Yu, Jiayi Wu, +6 authors, Kunwei Shen.
Oncol Lett, 2020 Jul 30; 20(2). PMID: 32724396    Free PMC article.
Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics.
Doris Leithner, Marius E Mayerhoefer, +4 authors, Katja Pinker.
J Clin Med, 2020 Jun 18; 9(6). PMID: 32545851    Free PMC article.
Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective.
Gouri Shankar Bhattacharyya, Dinesh C Doval, +3 authors, S P Somashekhar.
JCO Glob Oncol, 2020 Jun 09; 6. PMID: 32511068    Free PMC article.
Triple-negative pleomorphic lobular carcinoma and expression of androgen receptor: Personal case series and review of the literature.
Kohei Taniguchi, Shinichi Takada, +5 authors, Tadashi Yoshino.
PLoS One, 2020 Jul 23; 15(7). PMID: 32697770    Free PMC article.
Review.
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Andrew McGuire, Maire-Caitlin Casey, +11 authors, Michael J Kerin.
Cancers (Basel), 2020 Jul 11; 12(7). PMID: 32645898    Free PMC article.
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002.
Sergio Diotaiuti, Simona De Summa, +9 authors, Angelo Virgilio Paradiso.
Oncol Lett, 2020 Aug 13; 20(3). PMID: 32782565    Free PMC article.
Clinical Significance of Expression Changes and Promoter Methylation of PLA2R1 in Tissues of Breast Cancer Patients.
Noha Mitwally, Einas Yousef, Ahmad Abd Al Aziz, Mohamed Taha.
Int J Mol Sci, 2020 Aug 06; 21(15). PMID: 32751713    Free PMC article.
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.
Michela Palleschi, Roberta Maltoni, +16 authors, Sara Bravaccini.
Diagnostics (Basel), 2020 Aug 14; 10(8). PMID: 32784518    Free PMC article.
Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
Xiaoying Li, Yang Li, Xinmiao Yu, Feng Jin.
J Transl Med, 2020 Sep 02; 18(1). PMID: 32867770    Free PMC article.
Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer.
Barbara Bennani-Baiti, Katja Pinker, +6 authors, Andreas Stadlbauer.
Cancers (Basel), 2020 Jul 30; 12(8). PMID: 32721996    Free PMC article.
Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.
Jennifer Foglietta, Vienna Ludovini, +10 authors, Fausto Roila.
Genes (Basel), 2020 Aug 19; 11(8). PMID: 32806537    Free PMC article.
Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Haoyu Wang, Jiejie Yao, +3 authors, Kunwei Shen.
Cancer Med, 2020 Jul 14; 9(17). PMID: 32657039    Free PMC article.
Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era.
Fabio Corsi, Luca Sorrentino, +4 authors, Marta Truffi.
Medicine (Baltimore), 2020 Sep 03; 99(35). PMID: 32871890    Free PMC article.
Evaluating the current evidence to support therapeutic mammoplasty or breast-conserving surgery as an alternative to mastectomy in the treatment of multifocal and multicentric breast cancers.
Zoe Ellen Winters, Lorenzo Bernaudo.
Gland Surg, 2019 Jan 29; 7(6). PMID: 30687626    Free PMC article.
Review.
Malic Enzyme 1 Indicates Worse Prognosis in Breast Cancer and Promotes Metastasis by Manipulating Reactive Oxygen Species.
Chang Liu, Jun Cao, +4 authors, Xichun Hu.
Onco Targets Ther, 2020 Sep 15; 13. PMID: 32922044    Free PMC article.
Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy.
Xuran Zhao, Yu Tang, +17 authors, Yexiong Li.
Radiat Oncol, 2020 Sep 06; 15(1). PMID: 32887640    Free PMC article.
Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer.
Taru A Muranen, Sofia Khan, +41 authors, Heli Nevanlinna.
NPJ Breast Cancer, 2020 Sep 24; 6. PMID: 32964118    Free PMC article.
Associations Between Circulating Insulin-Like Growth Factor 1 and Mortality in Women With Invasive Breast Cancer.
Yifei Zhu, Tiange Wang, +7 authors, Kunwei Shen.
Front Oncol, 2020 Sep 26; 10. PMID: 32974138    Free PMC article.
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer.
Adil Allahverdiyev, Gamze Tari, Melahat Bagirova, Emrah Sefik Abamor.
J Breast Cancer, 2019 Jan 05; 21(4). PMID: 30607155    Free PMC article.
Review.
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.
Pelagia G Tsoutsou, Khalil Zaman, +3 authors, Marie-Catherine Vozenin.
Front Oncol, 2019 Jan 09; 8. PMID: 30619749    Free PMC article.
Review.
Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer.
Anne Herrmann, Frances Boyle, +2 authors, Nicholas Zdenkowski.
Health Sci Rep, 2017 Aug 22; 1(1). PMID: 30623032    Free PMC article.
Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers.
Michael Ulm, Arvind V Ramesh, +3 authors, Ramesh Narayanan.
Endocr Connect, 2019 Jan 15; 8(2). PMID: 30640710    Free PMC article.
Review.
Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors.
Nobuyuki Arima, Reiki Nishimura, +5 authors, Yasuo Toyozumi.
Oncol Lett, 2019 Jan 19; 17(1). PMID: 30655808    Free PMC article.
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Yukie Fujimoto, Hiromi Ozawa, +4 authors, Yasuo Miyoshi.
Mol Clin Oncol, 2019 Jan 27; 10(2). PMID: 30680208    Free PMC article.
Association of FOSL1 copy number alteration and triple negative breast tumors.
Leandro Tamião Rodrigues Serino, Tayana Schultz Jucoski, +6 authors, Enilze Maria de Souza Fonseca Ribeiro.
Genet Mol Biol, 2019 Mar 01; 42(1). PMID: 30816904    Free PMC article.
Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells.
Stefan Stefanovic, Thomas M Deutsch, +8 authors, Markus Wallwiener.
Cancers (Basel), 2019 Mar 14; 11(3). PMID: 30862027    Free PMC article.
Breast Cancer Prognosis Using a Machine Learning Approach.
Patrizia Ferroni, Fabio M Zanzotto, +3 authors, Mario Roselli.
Cancers (Basel), 2019 Mar 15; 11(3). PMID: 30866535    Free PMC article.
Association between digital breast tomosynthesis and molecular subtypes of breast cancer.
Siqing Cai, Miaomiao Yao, +4 authors, Huirong Huang.
Oncol Lett, 2019 Mar 15; 17(3). PMID: 30867729    Free PMC article.
Therapeutic Efficiency of an External Chinese Herbal Formula of Mammary Precancerous Lesions by BATMAN-TCM Online Bioinformatics Analysis Tool and Experimental Validation.
Guijuan Zhang, Xuefeng Jiang, +6 authors, Min Ma.
Evid Based Complement Alternat Med, 2019 Mar 25; 2019. PMID: 30906412    Free PMC article.
Complicated prognostic values of CCL28 in breast cancer by subtype.
Di-He Gong, Yi-Yu Chen, +3 authors, Ke-Da Yu.
J Thorac Dis, 2019 Apr 26; 11(3). PMID: 31019765    Free PMC article.
Male breast cancer: Specific biological characteristics and survival in a Portuguese cohort.
Saudade André, Teresa Pereira, +5 authors, António E Pinto.
Mol Clin Oncol, 2019 Apr 30; 10(6). PMID: 31031981    Free PMC article.
Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes.
Nour El Hoda S Ismael, Rasha A Khairy, Suzan M Talaat, Fatima A Abd El-Fattah.
Open Access Maced J Med Sci, 2019 May 22; 7(8). PMID: 31110566    Free PMC article.
Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer.
Tatsuo Shimura, Masahiko Shibata, +5 authors, Tohru Ohtake.
Oncol Lett, 2019 Jun 13; 17(6). PMID: 31186728    Free PMC article.
Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer.
Lizhe Zhu, Nan Ma, +5 authors, Yu Ren.
Oncol Lett, 2019 Jun 13; 17(6). PMID: 31186766    Free PMC article.
Should a Multigene Signature be Used in all Luminal Early Breast Cancers.
Nawale Hajjaji, Yves Marie Robin, Jacques Bonneterre.
Front Oncol, 2019 Jun 20; 9. PMID: 31214499    Free PMC article.
The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.
Jing Ning, Tamer M Fouad, +7 authors, Yu Shen.
J Cancer, 2019 Jul 02; 10(12). PMID: 31258771    Free PMC article.
Radiotherapy for initial clinically positive internal mammary nodes in breast cancer.
Jina Kim, Jee Suk Chang, +7 authors, Ik Jae Lee.
Radiat Oncol J, 2019 Jul 04; 37(2). PMID: 31266290    Free PMC article.
Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer.
Yi Heng Seow, Ru Xin Wong, +3 authors, Fuh Yong Wong.
J Breast Cancer, 2019 Jul 10; 22(2). PMID: 31281728    Free PMC article.
The potential influence of breast cancer estrogen receptors' distribution on active DNA demethylation.
Kinga Linowiecka, Olga Urbanowska-Domańska, Jolanta Guz, Marek Foksiński.
Contemp Oncol (Pozn), 2019 Jul 19; 23(2). PMID: 31316288    Free PMC article.
Review.
Gene Expression Assays for Early-Stage Hormone Receptor-Positive Breast Cancer: Understanding the Differences.
Ana Tablante Nunes, Deborah E Collyar, Lyndsay N Harris.
JNCI Cancer Spectr, 2017 Dec 11; 1(1). PMID: 31360834    Free PMC article.
Review.
Number of Risky Lifestyle Behaviors and Breast Cancer Risk.
Merete Ellingjord-Dale, Linda Vos, +6 authors, Giske Ursin.
JNCI Cancer Spectr, 2019 Jul 31; 2(3). PMID: 31360858    Free PMC article.
Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran.
Dena Firouzabadi, Alireza Rezvani, Amirreza Dehghanian, Laleh Mahmoudi.
Cancer Manag Res, 2019 Aug 03; 11. PMID: 31372050    Free PMC article.
Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression.
Mustapha Abubakar, Changyuan Guo, +9 authors, Xiaohong R Yang.
NPJ Breast Cancer, 2019 Aug 03; 5. PMID: 31372496    Free PMC article.
The cardiotoxicity effect of different chemotherapeutic regimens in Iraqi patients with breast cancer: A follow up study.
Zainab Nazar Hasan Anber, Basil Oied Mohammed Saleh, Safana Ali Al-Rawi.
Heliyon, 2019 Aug 14; 5(8). PMID: 31406940    Free PMC article.
The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.
Billy Shui-Wun Lai, Julia Y Tsang, +6 authors, Gary M Tse.
Oncologist, 2020 May 31; 25(9). PMID: 32472950    Free PMC article.
Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?
Giulia Bicchierai, Francesco Amato, +9 authors, Jacopo Nori.
Breast, 2020 Sep 06; 54. PMID: 32889303    Free PMC article.
Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
Harshima Disvini Wijesinghe, Gayani Kokila Wijesinghe, +4 authors, Menaka Dilani Samarawickrama Lokuhetty.
BMC Womens Health, 2020 Sep 16; 20(1). PMID: 32928183    Free PMC article.
Selecting suitable reference genes for qPCR normalization: a comprehensive analysis in MCF-7 breast cancer cell line.
Nityanand Jain, Dina Nitisa, Valdis Pirsko, Inese Cakstina.
BMC Mol Cell Biol, 2020 Sep 27; 21(1). PMID: 32977762    Free PMC article.
Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.
Shuai Yan, Wenjie Wang, +3 authors, Weiyang Tao.
Cancer Manag Res, 2020 Sep 29; 12. PMID: 32982426    Free PMC article.
Histology of Luminal Breast Cancer.
Ramona Erber, Arndt Hartmann.
Breast Care (Basel), 2020 Sep 29; 15(4). PMID: 32982642    Free PMC article.
Review.
Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival.
Paul W Sperduto, Shane Mesko, +36 authors, Minesh P Mehta.
Neuro Oncol, 2020 Feb 09; 22(9). PMID: 32034917    Free PMC article.
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
Kristina A Tendl-Schulz, Fabian Rössler, +15 authors, Zsuzsanna Bago-Horvath.
Virchows Arch, 2020 May 10; 477(4). PMID: 32383007    Free PMC article.
Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases.
Xun Xi, Xing-Wei Huang, +3 authors,